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ABSTRACT
A study of lipids in the plasma and erythrocyte membrane of 
patients suffering from depressive illness, patients with other 
psychiatric disorders and women using oral contraceptive agents is 
reported. It shows that there are differences in the concentrations 
of long chain polyunsaturated fatty acids (LCP) and linoleic acid 
(18:2oj6) in the plasma choline phosphoglycerides (CPG) and erythrocyte 
phospholipids of patients suffering from endogenous depression, patients 
suffering from postpartum depression and women using oestrogen and 
progestogen combined oral contraceptive agents, compared with those 
of matched controls. The expected effects of these differences on 
membrane function and the synthesis of prostaglandins and related 
compounds are discussed.
One of the aims of the study was to ascertain whether measurement 
of the LCP composition of the plasma CPG would be of value as a 
diagnostic tool for endogenous depression: although the difference from 
matched controls is highly significant (p < 0.001), it is concluded 
to be insufficient to be used as the sole diagnostic criterion.
The concentration of docosahexaenoic acid (22:6u>3) correlates with 
the severity of depression in the endogenous group, but not in the 
reactive group.
Total plasma cholesterol is low in the endogenous group compared 
with controls, but there is no abnormality in the free; esterified 
ratio. There is no difference in the total plasma CPG, the relative 
proportions of erythrocyte phospholipids or the ratio of cholesterol: 
phospholipid in erythrocytes between any of the groups of psychiatric 
patients and matched controls.
The phospholipid LCP concentrations normalise with clinical 
improvement in the endogenous group, hut are unaltered in the reactive 
group. Patients receiving prophylactic lithium treatment have similar 
concentrations of LCP in their plasma CPG to matched controls.
Possible reasons for the differences in phospholipid LCP 
concentrations are investigated and discussed.
Finally, some suggestions for future research are made.
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CHAPTER ONE
INTRODUCTION
Depression, defined as ’’the lowering of mental and physical 
vitality to the point of distress” (Watts, 1973), is the commonest of 
mental illnesses. It affects two to three times as many women as men 
(Weissman and Klernian, 1977; Callan, 1979) and episodes occur more 
frequently in Spring and Autumn than at other times of the year (Eastwood 
and Peacocke, 1976).
Due to the heterogeneity of the disorder numerous attempts have 
been made to produce a suitable classification system and this has 
resulted in one of the greatest controversies in psychiatry today. The 
endogenous/reactive dichotomy is the most widely used, the argument 
being whether they constitute distinct categories (Kiloh and Garside,
1963; Mendels and Cochrane, 1968; Kiloh et al., 1972; Spicer et al., 1973; 
Cochrane, 1977; Checkley, 1979) or are opposite ends of a continuum 
(Kendell, 1968; 1972; 1976). Endogenous depression is said to be due to 
internal factors such as a metabolic abnormality not yet elucidated and 
has a strong hereditary element, whereas reactive depression occurs in 
response to environmental factors in vulnerable personalities. Endogenous 
depression can be subdivided into bipolar (alternating mania and depression) 
and unipolar (depression only) illness. The clinical characteristics of 
endogenous and reactive depression are compared in Table 1. However, the 
dividing line is not clear in all cases: according to Kendell (1972) 
patients with mixed symptoms are more common than those with pure 
symptoms of either group. Also it has been pointed out that attacks of 
endogenous depression may be precipitated by adverse environmental 
influences (Kiloh and Garside, 1963). It is important to accurately
distinguish between the two types in order to decide upon suitable 
treatment COarney and Sheffield, 1973; BielsRi, 1976; Davidson et al,9 
1977; Royal College of Psychiatrists, 1977; Freeman, 1979). If an 
endogenous depressive is incorrectly diagnosed, months or even years 
of invalidism may result or the patient may end it all by suicide.
TABLE 1
« . &■ Clinical Characteristics of Endogenous and Reactive Depression
Endogenous Depression Reactive Depression
Age: 40 yrs or older. 
Early awakening.
Depression worse in morning, 
gradually improving throughout 
the day.
General slowing up in thinking
and activity (psychomotor retardation),
Energy and libido markedly reduced.
Agitation usually present.
Marked feelings of inferiority, 
uselessness and hopelessness.
Delusions and hallucinations may 
be present.
Reduced appetite and loss of 
weight.
Age: usually under hO yrs.
Difficulty in going off to 
sleep and further interruptions,
Depression worse, if at all, 
in the evening and when 
alone.
Anxiety and irritability.
Energy variably reduced.
Agitation not present.
Not marked, but other 
variations in personality 
may be present.
Delusions and hallucinations 
do not occur.
Usually little change in . 
appetite and weight.
Summarised from Dominion (1976).
Clearly the classification system is in urgent need of revision.
Alternative systems have been proposed (Pollitt, 1965; Overall 
et al,9 1966; Blinder, 1966; Paykel, 1971; Kerry and Orme, 1975) but 
none have been widely accepted.
HEREDITARY ASPECTS OF DEPRESSION
To ascertain whether there is a genetic component in endogenous 
depression both twin and family studies were examined. Data from twin 
studies showed an overall concordance rate of 76 percent for 
monozygotic (MZ, identical) twins and 19 percent for dizygotic (DZ, 
fraternal) twins (Tsuang, 1975). The concordance rates for MZ twins 
varied between 33 percent and 93 percent compared with 0 to 39 percent 
for DZ twins (Perris, 1976; Mendlewicz, 1977). Although concordance 
was significantly higher for MZ than for DZ twins it was still well 
below the expected 100 percent which would have proven more 
conclusively the involvement of genetics. The interpretation of the 
results is complicated by the fact that environmental influences tend 
to be more similar for MZ than for DZ twins. Only twelve pairs of MZ 
twins who had been reared apart since childhood have been studied: 
eight pairs (67 percent) showed concordance (Price, 1968), a rate similar 
to that reported by Tsuang (1975). These results suggest the presence 
of a genetic factor in endogenous depression.
A re-analysis of twin data based on the unipolar/bipolar 
classification revealed that 86 percent of MZ twins were concordant 
for one or other form of the illness (Mendlewicz, 1977). This suggests 
that unipolar and bipolar depression might be genetically separate.
Data from family studies showed that there was a significantly 
greater rate of endogenous depression in first-degree relatives (parents, 
siblings and children) of endogenous depressives than in the general 
population (Angst, 1974; Tsuang, 1975; Perris, 1976; Mendlewicz, 1977; 
Trzebiatowska-Trezeciak, 1977) suggesting a genetic component. 
Trzebiatowska-Trezeciak (1977) found a lower morbidity risk for second- 
degree relatives than for first-degree relatives and also found different
morbidity risks for unipolar and bipolar depression, suggesting that 
the two illnesses are distinct entities.
The precise mode of inheritance is. unknown but different models 
have been proposed: a single dominant or polygenic type (Tsuang, 1975; 
Perris, 1976; Mendlewicz, 1977). An X-linked factor has been found 
in some bipolar families but not in those with unipolar illness 
(Cadoret, 1976). Unipolar depression has been suggested to consist of 
three or more separate illnesses each with its own mode of inheritance 
(Schlesser et al., 1979).
BIOLOGICAL STUDIES OF DEPRESSION
Since the beginning of this century the biological aspects of 
depression have received considerable attention. Virtually all the 
known constituents of blood, urine and cerebrospinal fluid (CSF) have 
been measured and pathological studies of brain and other organs 
conducted. However, many positive findings have been contradicted 
in the course of time and even in the more recent literature, after 
the introduction of antidepressant drugs in the lGSO's, a great deal 
of controversy was seen. Inadequate control of factors such as age, 
sex, body weight, diet and administration of drugs other than 
antidepressants undoubtedly contributed to this.
The main areas of research have been biogenic amines, electrolytes 
and hormones. In reviewing the literature biological systems will be 
discussed individually for convenience but it must be remembered that 
they interact with each other in a complex manner and that changes in 
in one may lead to changes in others.
(a) Biogenic Amines
Interest in the association between biogenic amines and emotion 
stemmed from Cannon’s discovery in the early 1900*s that animals 
secreted increased amounts of adrenalin when exposed to situations 
inducing rage or fear. Further stimulus to the investigations came 
from two accidental observations. Firstly, a small but significant 
number of patients treated with reserpine for hypertension developed 
a condition clinically similar to endogenous depression (Harris, 1957) 
and secondly, tubercular patients being treated with iproniazid 
responded with a much brighter mood than would be expected from 
clinical improvement (Pare and Sandler, 1959). Pharmacological studies 
indicated that reserpine depleted noradrenalin, dopamine and serotonin 
C5-hydroxytryptamine,5HT) within the central nervous system (CNS)
(Shore e t  a l .  , 1955; Carlsson et al,, 1957) and that iproniazid increased 
these amines (Spector e t  a l . ,  1958). These findings led to the 
formulation of the biogenic amine hypothesis of affective disorders 
(Pare and Sandler, 1959; Prange, 1964; Schildkraut, 1965; Bunney and 
Davis, 1965; Lapin and Oxenkrug, 1969; Ashcroft e t  a l . , 1972). Briefly 
this suggests that depression is associated with a deficiency of 
noradrenalin and/or serotonin at functionally important receptor sites 
in the brain whereas mania is associated with an excess of the amine(s). 
More recently it has been postulated that cholinergic factors are also 
involved in the regulation of affect (Janowsky e t  a l . , 1972; Davis, 1975). 
Both depression and mania were said to represent an imbalance of the 
adrenergic-cholinergic system, depression being the result of cholinergic 
predominance and mania the result of adrenergic predominance*. In 
support of this hypothesis, Tamminga e t  a l .  (1976) noted the occurrence 
of depression after treatment with oral choline.
Noradrenalin, dopamine and serotonin together with acetylcholine
function as transmitter substances within the peripheral nervous 
system and there is general agreement that they play a similar role 
in the CNS although the individual synapses have not been elucidated.
The area of the brain concerned with emotion is the limbic system of 
which the hypothalamus is part. Noradrenalin and serotonin are present 
in many areas of the brain but dopamine is found almost exclusively 
in the basal ganglia (Schildkraut and Kety, 1967). The highest 
concentrations of noradrenalin and serotonin have been said to occur 
in the hypothalamus (Schildkraut and Kety, 1967) yet serotonin 
concentrations four times greater than those of the hypothalamus have 
been reported in certain raphe nuclei of the pons-raedulla of the 
lower brainstem (Lloyd et al., 1974). Centres controlling eating, 
drinking and sleeping are situated in the hypothalamus and there may be 
a link between the biogenic amines and these functions: the relationship 
between serotonin and sleep is well known (Koella, 1974).
Noradrenalin and dopamine are synthesised from the amino acid 
L-tyrosine which in turn can be formed from L-phenylalanine, Serotonin 
is synthesised from the amino acid L-tryptophan. Catecholamine 
formation, catecholamine catabolism and serotonin metabolism are shown 
in Figures 1, 2 and 3 respectively.
(i) Blood Studies
Early studies failed to differentiate between depressed and 
normal subjects on the basis of plasma catecholamine concentrations 
(Manger et al., 1957; Reilly and Regan, 1957). However the methods 
available at that time were neither sensitive nor specific enough to 
measure catecholamine values reliably. In a more recent study Wyatt
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et al. (1971), contrary to the biogenic amine hypothesis, found 
catecholamines significantly elevated in drug-free depressed patients 
compared with normal controls. The values decreased with amelioration 
of the depression.
Serotonin concentrations have been shown to be normal in serum 
(Kaneko et a l . , 1975) but reduced in platelets (Copper et a l . ,  1976) 
of patients suffering from depressive illness. Takahashi (1976) found 
that platelet serotonin concentrations were lower in patients with 
bipolar depression than in those with unipolar depression or in controls. 
Other workers have reported reduced serotonin uptake by platelets of 
depressed patients (Hallstrom et a l . ,  1976; Tuomisto and Tukiainen, 1976; 
Coppen et a l . ,  1978: Coppen et a l . ,  1980), indicating an abnormality 
in membrane transport of serotonin. Oxenkrug et a l .  (.1978) demonstrated 
a circadian rhythm for serotonin uptake by platelets and found that this 
was altered in depressive illness.
Monoamines are unable to enter the brain from the vascular system 
unlike their precursor amino acids. Tryptophan differs from other amino 
acids in that it exists in the plasma mainly bound to albumin (McMenamy 
and Oncley, 1958). Some investigators have suggested that the level of 
brain tryptophan and hence serotonin synthesis is related to the 
concentration of free tryptophan in the plasma (Fernstrom and Wurtman,
1971; Knott and Curzon, 1972; Tagliamonte et al., 1973), whereas others 
have reported that total plasma tryptophan predicts brain tryptophan 
concentrations (Fernstrom et al., 1976; Wiryanti, 1980).
No difference has been found in the total plasma tryptophan 
concentrations of depressed patients compared with controls (Coppen et a l . ,  
1972a; Coppen et a l . ,  1973a; Aylward and Maddock, 1973;. Niskanen et a l . ,  
1976; Coppen and Wood, 1978). Reduced plasma free tryptophan has been
reported in depressive illness by some (Coppen et a l . ,  1972a; Coppen- 
et a l , ,  1973a; Aylward and Maddock, 1973; Coppen and Wood, 1978) but 
not all investigators (Niskanen et a l . ,  1976; Riley and Shaw, 1976; 
Garfinkel et a l . ,  1976), Reasons for this discrepancy were discussed 
by Coppen and Wood (1978): the heterogeneity of the illness, differences
in methodology and differences in the antidepressant-free period prior 
to the studies (shorter drug-free periods resulting in higher free 
tryptophan levels), appear to be the most likely explanations. Differences 
in diet were not thought to be a factor as this would have resulted in 
altered total plasma tryptophan concentrations. Free tryptophan levels 
have been reported to increase on recovery (Coppen et a l . ,  1973a;
Coppen and Wood, 1978) but this has been contradicted (Peet et al., 1976).
The concentrations of other plasma neutral amino acids (Phenylalanine,, 
tyrosine, leucine, isoleucine and valine) may also affect brain 
tryptophan concentrations as they compete with tryptophan for the same 
transport system (Fernstrom and Wurtman, 1972). Miller and Amdisen (1979) 
reported a reduced ratio of tryptophan to other neutral amino acids in 
the plasma of a single bipolar depressed patient compared with controls. 
Administration of a tryptophan load led to increased plasma concentrations 
of the competing amino acids in the patient compared with a decrease in 
the control subjects. The authors concluded that there is a dysfunction 
of processes mediating active transport of tryptophan and other neutral 
amino acids to the brain and tissues. Their results are however of 
questionable value since only one depressed patient was studied.
Takahashi et al, (1968) measured fasting plasma tyrosine levels of 
patients suffering from manic-depressive illness and found no difference 
from controls. B'enkert et al, (1971) investigated 2q-hour plasma 
tyrosine concentrations and reported reduced 11 a.m. values in patients 
with endogenous depression. This was disputed by a more recent study
(Niskanen et al., 1976).
Rosenblatt et al. (1979) measured twenty amino acids in the plasma 
and erythrocytes of patients suffering from endogenous depression and 
controls. There was no differences in the plasma amino acid 
concentrations of the two groups but patients with endogenous depression 
had significantly greater amounts of glycine in their erythrocytes.
This was unaltered by electroconvulsive therapy (EOT) or by clinical 
improvement.
There have also been several studies of the activity of enzymes 
involved in the formation and catabolism of catecholamines and serotonin 
but these have failed to show any consistent abnormality.
Shopsin et al, (1972) measured serum dopamine-8-hydroxylase 
activity (the enzyme catalysing the conversion of dopamine to noradrenalin, 
see Figure 1) in patients with bipolar depression, unipolar depression, 
schizophrenia and in patients with character disorders, but were unable 
to differentiate between any of the groups. Van Cauter and Mendlewicz 
(1978) established a circadian rhythm for the enzyme and found that this 
was altered in endogenous depression.
Monoamine oxidase (MAO) is involved in the catabolism of both 
catecholamines (Figure 2) and serotonin (Figure 3). Its activity tends 
to be higher in females than in males (Murphy and Costa, 1975) and to
increase with age (Robinson et al., 1972). Feldstein et al, (1964)
14 14studied the conversion of C-serotonin to C-5-hydroxyindole acetic acid
(5HIAA) as a quantitative index of MAO activity and found no difference
between depressed patients and controls. More recently platelet MAO
activity has been investigated. Nies et al, (1971) found higher
platelet MAO activity in depressed patients than in controls. Bipolar
depressed patients have been reported to have low (Murphy and Weiss,
1972; Landowski et al,, 1975; Sullivan et al,, 1977), high CBelmaker 
et al. , 1976) and normal (.Takahashi, .1977; Edwards et al,, 1978) MAO 
activity compared to those with unipolar depression and controls,
Leckman et al. (1977) reported low MAO activity in first-degree 
relatives of bipolar depressives but were unable to distinguish well 
from ill members of the families. They suggested that this may be an 
indicator of increased familial vulnerability to endogenous depression.
The inconsistencies between these studies may have been due to the use 
of different substrates for MAO and to differences in sample size.
Catechol-O-methyl transferase (COMT) is involved in the catabolism 
of catecholamines (Figure 2). Erythrocyte COMT activity has been 
reported to be low in endogenous depression by some investigators (Cohn 
et al., 1970; Dunner et al.,1971) but normal by others (White et al.,
1976; Dunner et al., 1977). The discrepancy is probably due to differences 
in methodology. The earlier studies used a poorer COMT substrate 
(noradrenalin) than the later studies (3,4-dihiydroxy benzoic acid) and 
employed a very low concentration of the methyl donor, S-adenosyl-L- 
methionine (SAM), so that enzyme activities were obtained under conditions 
of limited substrate concentration (White et al., 1976). Differences 
may also have been due to the heterogeneity of the disorder since 
Shulman et al. (1978) reported that among patients suffering from 
endogenous depression, those with agitation had COMT activities 
significantly greater than controls whereas those with retardation had 
lower COMT activities than controls. Davidson et al. (1976) found that 
patients with reduced COMT activity responded well to treatment with 
imipramine.
Andreoli et al. (1978) measured the blood SAM concentrations of 
depressed patients and controls but found no difference between the two 
groups.
• (ii) Urine Studies
The measurement of urinary amine metabolites has been used to 
explore the relationship between biogenic amines and depressive 
illness. Unfortunately it is impossible to conclude much about brain 
function from these studies since only about 5 per cent of each 
metabolite is of central origin, with the exception of 3-methoxy^H- 
hydroxy phenylglycol (MHPG) (Maas and Landis, 1968 ; Ebert and Kopin, 
1 9 7 5 ) . There is a diurnal variation in catecholamine excretion and also 
a multitude of other factors which influence urinary levels. These 
include body weight, diet, alcohol, nicotine, stress, muscular work, 
anxiety, postural changes, motor activity, urinary volume and pH and 
administration of certain drugs such as chloral hydrate and meprobamate 
(Shopsin et al,, 1 9 7 4 ) .
Considering the lack of control for some or all of these factors 
in the literature, it is hardly surprising that results have been very 
inconsistent. Noradrenalin excretion has been found to be reduced 
(Strom-Olsen and Weil-Malherbe, 1 9 5 8 ) ,  normal (Bergsman, 1 9 5 9 ) and 
increased (Curtis e t  a l . ,  1960; Bunney e t  a l . ,  1 9 6 7 ) in depressed 
patients. Bunney and his co-workers (1 9 6 7 ) reported that patients 
suffering from psychotic (endogenous) depression excreted greater amounts 
of noradrenalin, 3-methoxy-4-hydroxy mandelic acid (VMA), metanephrine 
and 3,4-dihydroxy mandelic acid than those suffering from neurotic 
(reactive) depression. More recently, Deleon-Jones e t  a l .  (1 9 7 5 )  were 
unable to find any difference between subgroups of depressed patients 
and controls in the urinary excretion of normetanephrine, metanephrine 
or VMA.
MHPG excretion has been found to be reduced in some depressed 
patients and raised in others (Maas et a l . ,  1968 ; Greenspan et a l . ,  1 9 7 0 ;
Bond et al., 1972; Schildkraut, 1973; Deleon-Jones et al., 1975;
Pickar et al., 1978; Taube et a l . ,  1978; Garfinkel et a l . ,  1979). It 
has been suggested that the excretion of this metabolite may provide a 
useful predictor of response to tricyclic drug therapy in unipolar 
but not bipolar depressed patients: low pretreatment levels of MHPG 
indicating favourable response to iraipramine and high levels indicating 
favourable response to amitriptyline (Fawcett et a l . ,  1972; Schildkraut, 
1973; Mendels et a l . ,  1976). MHPG excretion is unaffected by physical 
activity (Pickar et a l . , 1978), It is however affected by diet in 
depressed patients but not in controls (Muscettola et a l , ,  1977). This 
suggests that normal controls may not be suitable for evaluating the 
contribution of some potential sources of variance in amine metabolism 
in depressive illness. Wehr et a l .  (1980) demonstrated a circadian 
rhythm for MHPG excretion and reported that this was abnormal in bipolar 
depressive illness.
Serotonin excretion has been reported to be 50 percent lower 
during depressive illness than on recovery or in normal subjects 
(Coppen et a l . ,  1965,; Coppen, 1972). Cazzullo et a l .  (1966) found that 
5HIAA excretion was normal in depressed patients, but Amamoto and Sarai 
(1976) reported low values after an oral load of 5-hydroxytryptophan.
Recent studies have shown decreased urinary levels of trace amines, 
tyramine and octopamine, and their metabolites (see figure 4) in 
depressive illness (Bonham Carter et a l . , 1978; Sandler et a l . ,  1979a). 
However, as the authors pointed out, a substantial proportion of these 
metabolites may derive from the diet or gut flora.
(Hi) CSF Studies
CSF became the focus for the study of amine metabolism due to its
Figure H
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contiguity to brain and partial isolation from the periphery. 
Nevertheless, there are problems associated with the interpretation of 
such studies and as with blood and urine investigations findings have
i ‘ -
been inconsistent.
Dencker et a l .  (1966a) reported noradrenalin levels three times 
greater in depressed patients than in controls but this has not been 
confirmed (Post et a l . ,  1978). The latter group did however find 
higher levels in patients with high anxiety compared to those with low 
anxiety. Reduced levels of MHPG have been reported in endogenous 
depression by some investigators (Gordon and Oliver, 1971; Post et al., 
1973a) but not by others (Shopsin et a l . ,  1973; Vestergaard et a l . ,
1978). Homovanillic acid (HVA), a metabolite of dopamine, has been shown 
to be low (Papeschi and McClure, 1971) and high (Vestergaard et al.,
1978) in endogenous depression.
5HIAA levels have been reported to be low in depressive illness by 
some investigators (Ashcroft and Sharman, 1960; Ashcroft et a l . ,  1966; 
Dencker et a l . ,  1966b; Coppen, 1972) but not by others (Bowers et a l . ,  
1969; Papeschi and McClure, 1971; Vestergaard et a l . ,  1978). Tryptophan 
has also been found to be low in the CSF in depressive illness (Coppen 
et a l . ,  1972b).
Sandler et al(1979b) measured phenylacetic acid (see Figure *0 in 
the CSF of patients with depressive illness and in controls. Depressed 
patients had lower levels, indicating a possible deficiency of trace 
amine (tyramine and octopamine) production.
GABA (Y-amino-butyric acid), a major inhibitory neurotransmitter, 
has been shown to be reduced in the CSF of patients suffering from 
depressive illness (Gold et al., 1980). The biological significance of 
this is unknown but may relate to the proposed noradrenergic mechanisms
in depressive illness (Maas, 1975; Biwas and Carlsson, 1977; Arbilla 
and Langer, 1979),
The variability between studies may be the result of differences 
in the procedure used to obtain spinal fluid, the volume of fluid used 
and variations in physical activity of the subjects (Post and Goodwin, 1975). 
Also several of the fluorimetric methods used to assay HVA and 5HIAA are 
not very reliable when used to measure the low basal concentrations 
of these metabolites found in lumbar fluid (Wilk and Green, 1972). 
Interpretation of the results is complicated by the fact that although 
most HVA is derived from the brain (Papeschi e t  a l . ,  1971; Post e t  a l . ,
1973b) significant amounts of 5HIAA and MHPG are also derived from sources 
in  the spinal cord (Bulat and Zivkovic, 1971; Post e t  a l . ,  1973b; Weir 
e t  a l . ,  1973) and by the fact that there is active transport of metabolites 
out of the CSF (Moir e t  a l . ,  1970). Thus changes in lumbar 
concentrations of metabolites may reflect changes in transport out of 
the CSF rather than changes in turnover in the CNS.
In an attempt to obtain more consistent results, several 
investigators studied the accumulation of metabolites in lumbar fluid 
after the administration of probenecid. Probenecid blocks active 
transport of 5HIAA and HVA from the CSF, thereby increasing the 
reliability of the fluorimetric assay and providing a more accurate 
reflection of ventricular levels. Low levels of 5HIAA and HVA have been 
found in endogenous depression (van Praag and Korf, 1971; Goodwin et al.9 
1973; van Praag et al., 1973; Post and Goodwin, 1975). Bowers (1974) 
showed that levels of 5HIAA and HVA were lower in bipolar depression 
than in unipolar depression: patients with unipolar depression had normal 
5HIAA levels but increased VMA levels. Noradrenalin levels have been 
reported to be normal in depressive illness (Post et al., 1978).
As pointed out by Mendels et al. (1976) the probenecid technique' 
is not without its problems: there may be variations in probenecid 
absorption with consequent differences in CSF probenecid concentration 
and degree of blockade of transport obtained and also possible effects 
of probenecid itself on brain tryptophan concentration and serotonin 
turnover. Nevertheless, more consistent results have been reported using 
this technique.
The influence of dietary factors on CSF amine metabolite 
concentrations cannot be excluded: Botez et al. (1979) have shown that 
reduced 5HIAA concentrations occur in the CSF of folic acid deficient 
subjects.
(iv) Post-Mortem Studies
Serotonin (Shaw et al., 1967; Pare et al., 1969) and 5HIAA (Bourne 
et al., 1968) concentrations have been found to be significantly lower in 
the brains of subjects who had committed suicide compared to those of 
subjects who had died of other causes. There was no significant difference 
in noradrenalin (Bourne.et al., 1968; Pare et al., 1969) or dopamine 
(Pare et al., 1969) concentrations. Lloyd et al. (1974) studied discrete 
brain areas and found that serotonin levels were significantly reduced in 
the raphe nuclei dorsalis and centralis inferior. Normal concentrations 
of serotonin were found in the higher brainstem and telencephalon, but 
5HIAA was increased in the maramiliary bodies.
There are several problems associated with the.interpretation of 
post-mortem studies. It may be difficult to obtain reliable data concerning 
diagnosis, diet and drugs taken by the patient. It is also difficult to 
control for losses of brain amines after death. The brain should be removed
from the skull and deep-frozen immediately after death, otherwise large 
losses of serotonin occur CJoyce, 1962), Even storage itself may have 
an effect on brain serotonin and 5HIAA content: according to Dowson 
(1969) there is a significant fall in serotonin and 5HIAA concentrations 
between one and twenty six days storage, resulting in a loss of 34 percent 
of the serotonin and 44 percent of the 5HIAA. The decay process may 
also be influenced by changes in serotonin metabolism associated with 
depression. Clearly, further, study is required in this area.
(b) Electrolytes
There are many reports in the literature suggesting that disturbances 
of electrolyte metabolism occur in depression. These are of importance 
since electrolytes play a central role in several aspects of neuronal 
function: Maintenance of the resting potential; carrying the current 
required for the action potential; synthesis, storage, release and 
inactivation of neurotransmitters; and in carrying the current responsible 
for depolarization of postsynaptic membranes (Bogdonski and Brodie,
1966; Bogdonski et al., 1968; Wright, 1971; Molinoff and Axelrod, 1971; 
Jimerson et al., 1979).
A critical factor in the maintenance of the resting potential is 
that neuronal cytoplasm is low in sodium and chloride but rich in 
potassium, with the reverse occurring in the extracellular fluid. The 
cell membrane is freely permeable to potassium and chloride but 
relatively impermeable to sodium: sodium which leaks into the cell is 
extruded by an active transport mechanism, the "sodium pump".
Stimulation of a nerve fibre produces a transient increase in membrane 
permeability to sodium and this sets off an action potential which is 
propagated along the fibre.
(i) Sodium, Potassium and Water
Electrolyte studies were prompted by the discovery of Schottstaedt 
e t  al, (1956) that periods of depression in normal subjects were 
accompanied by a reduction in urinary excretion of sodium. Investigations 
have suggested that clinical depression is associated with a retention 
of sodium which is reduced on recovery (Anderson and Dawson, 1963;
Coppen and Shaw, 1963; Baer et al,t 1969; Bjorum et al., 1972). The 
original observation by Gibbons (1960) of a reduction in exchangeable 
sodium on recovery from depressive illness was not confirmed by Coppen 
e t  al, (1962) nor by the balance studies of Russell (1960). It has been 
suggested that the sodium retained results in increased residual sodium 
(intracellular plus some bone sodium) (Coppen and Shaw, 1963; Cox e t  al.,
i '
1971).
Another approach to the study of sodium metabolism in depressive 
illness has been the measurement of the rate of entry of radioactive 
sodium into the CSF. Coppen (1960) reported a decrease in the rate of
2ii .
entry of Na from blood into CSF in a group of thirty one depressed patients
which returned to normal on recovery. This was not confirmed (Fotherby
e t  al., 1963;. Carroll e t  al., 1969). Fotherby et al. (1963) discovered
24that exercise significantly increased the transfer rate of Na and 
hence decreased physical activity in depressed patients could account 
for the reduced transfer rate reported by Coppen (1960),
Plasma and erythrocyte sodium concentrations have been determined 
in depressive illness. Plasma sodium has been shown to be reduced 
(Sharma e t  al., 1970), normal (Bjorum, 1972) and increased (Ramsey e t  al.,
1979) during the illness, with no alteration on recovery (Coppen and Shaw, 
1963; Bjorum, 1972). Erythrocyte sodium levels of patients with 
endogenous depression have been found to be normal (Naylor e t  al., 1970a;
Ramsey e t  al., 1979) and low (Mendels e t  al., 1972) compared with 
controls; a reduction (Naylor e t  al., 1971), no alteration (Mendels 
e t  al., 1972), and an increase (Mendels and Frazer, 1975) have been 
reported with clinical improvement.
Total body potassium (TBK) has been shown to be low (Shaw and 
Coppen, 1966) and normal (Platman et al., 1970) and intracellular 
potassium (ICK) to be low (Shaw and Coppen, 1966; Abe and Coppen, 1969) in 
depressed patients compared with controls. The control group of Shaw 
and Coppen (1966) was unfortunately compiled from another study. No 
alteration has been reported in exchangeable potassium (Gibbons, 1960),
ICK (Shaw and Coppen, 1966; Abe and Coppen, 1969) or TBK (Coppen and 
Shaw, 1963; Shaw and Coppen, 1966; Baer et al., 1970 ; Platman et al.,
1970) on recovery from depressive illness.
Plasma potassium has been found to be high (Sharraa et al., 1970) 
and low (Bjorum, 1972) in depressive illness with no alteration on 
recovery (Coppen and Shaw, 1963). There was no difference in erythrocyte 
potassium concentrations in patients suffering from depressive illness 
compared with controls (Naylor e t  al., 1970a; Mendels e t  al., 1972) or 
on recovery (Naylor e t  al., 1971; Mendels e t  al., 1972). Urinary excretion 
of potassium was normal in depressive illness (Sharma e t  al., 1970) but 
increased significantly with clinical improvement (Bjorum e t  al., 1972). 
Paschalis e t  al. (1977) examined sweat electrolytes of bipolar depressed 
patients and found reduced potassium levels compared with controls.
Extracellular fluid (ECF) volume has been shown to be low in depressive 
illness (Shaw and Coppen, 1966). Total body water (TBW) (Coppen and Shaw, 
1963; Coppen and Shaw, 1967; Abe and Coppen, 1969), ECF (Coppen. and Shaw, 
1963; Brown et al., 1963) and intracellular water (ICW) (Coppen and Shaw, 
1967; Abe and Coppen, 1969) have been reported to increase with clinical
improvement, Shaw and Coppen (1966) however, found no change in ECF • 
volume on recovery.
The first direct test of an electrolyte hypothesis of depression 
using human brain tissue was carried out by Shaw and his colleagues 
(1969). Brains of subjects who had committed suicide contained more 
water and less sodium (expressed as mEq/lOOg fat free weight) than 
brains of subjects who had died of natural causes. The potassium content 
was similar in both groups. They interpreted their results to indicate 
that in depression the brain extracellular space may be contracted and 
the intracellular space enlarged, resulting in a reduction of the 
intracellular potassium concentration.
These conflicting reports of sodium and potassium levels in 
depressive illness could have arisen from differences in diagnosis, 
failure to control diet by some investigators, differences in Metabolic11 
control and in choice of control groups. There may even be differences 
between depressives and controls in their attitudes to admission to a 
metabolic ward. The use of patients as their own controls i.e. depressed 
and recovered avoids some of these difficulties but gives more limited 
information. The discrepancy between the results of Sharma et al. (1970) 
and Bjorum (1972) of plasma sodium and potassium levels in depressive 
illness appear to be due to differences in sample size (Bjorum*s sample 
being much larger) and in the constancy of the changes observed.
A reduction in active transport of sodium across erythrocyte 
membranes has been found in endogenous depression by some (Naylor et al,9 
1970b; Hesketh e t  a l . ,  1977; Choi e t  a l . ,  1977; Scott and Reading, 1978) 
but not all investigators (Naylor e t  a l . ,  1973; Frazer e t  a l . ,  1978).
Here again, differences may have arisen from differences in diagnosis 
and in selection of controls.
A reduction in intracellular potassium and increase in intracellular 
sodium would tend to increase the excitability of cell membranes 
(Coppen, 1967). It has been suggested that neurones are hyperexcitable 
in depressive illness (Whatraore, 1966; Whybrow and Mendels, 1969) and 
that receptors are supersensitive (Shaw et al., 1977; Friedman, 1978).
(ii) Calcium and Magnesium
Studies of calcium and magnesium have been more limited than those 
of sodium and potassium and have yielded more conflicting results.
Serum calcium has been reported to be high (Hakim et al,9 1975a), 
normal (Naylor e t  al., 1972) and low (Frizel e t  al., 1969; Bjorum, 1972) 
in depressive illness and to decrease following treatment (Bjorum, 1972; 
Carman e t  al., 1977). Urinary excretion of calcium has been found to be 
low (Sharma e t  al., 1970) and normal (Bjorum e t  al., 1972) in endogenous 
depression and to decrease with clinical improvement (Flach, 196*+).
CSF calcium has been shown to be high (Hakim e t  al., 1975b) and normal 
(Jimerson e t  al., 1979) in endogenous depression and to decrease on 
recovery (Carman e t  al., 1977; Jimerson e t  al., 1979; Carman and Wyatt, 
1979).
Serum magnesium has been reported to be high (Cade, 1961+; Bjorum, 
1972; Hakim e t  al., 1975a), normal (Naylor e t  al., 1972) and low (Frizel 
et al., 1969) in depressive illness and to increase on recovery (Cade, 
196*+; Frizel e t  al., 1969). Goodwin e t  al. (1968) found raised plasma 
magnesium levels in bipolar but not unipolar depression. Urinary 
excretion of magnesium was low in endogenous depression and increased 
on recovery (Bjorum e t  al., 1972). CSF magnesium levels were higher 
in patients with endogenous depression than in those with reactive
depression or controls (Hakim et al., 1975b).
The most likely explanation for these conflicting results of 
calcium and magnesium levels in depressive illness is differences in 
methodology:'., the studies of Cade (1961+) and Hakim et al. (1975a,b) 
used colorimetric methods; Frizel et al. (1969) used an ion exchange 
strip; Bjorum and others used atomic absorption spectrophotometry.
The latter is the most accurate for the determination of calcium and 
magnesium. As with sodium and potassium studies, inconsistencies may 
have also arisen from differences in diagnosis, failure to control 
diet by some investigators, differences in ■'metabolic*' control and in 
selection of control subjects.
(c) Hormones
Most of the research concerning hormones in depressive illness has 
concentrated on the corticosteroids although growth hormone, luteinizing 
hormone, prolactin and thyroid hormone have been studied.
(i) Corticosteroids
There have been a vast number of studies producing evidence of 
increased adrenocortical activity in depressive illness. Plasma 
corticosteroid levels were shown to be.raised, particularly in the 
morning and there was a greater degree of diurnal variation in depressed 
patients compared with controls (Board et a l . ,  1957; Gibbons and McHugh, 
1962; Doig et a l . . ,  1966; Bridges and Jones, 1966; McClure, 1966a;
Hullin et a l . ,  1967; Butler and Besser, 1968; Fullerton et a l . ,  1968; 
Sachar et a l . ,  1973a; Sachar, 1975). Plasma levels correlated with the
severity of the illness (Gibbons and McHugh, 1962; McClure, 1966a) 
and were found to decrease on recovery by most (Board et a l . ,  1957; 
Gibbons and McHugh, 1962; Bridges and Jones, 1966; Doig e t  a l . ,  1966; 
McClure, 1966b; Brooksbank and Coppen, 1967; Hullin e t  a l . ,  1967) 
but not all investigators (Fullerton e t  a l . , 1968). Studies of plasma 
cortisol-binding capacity showed that this was normal in depressive 
illness (King, 1973; King, 1975).
Raised twenty-four hoururinary corticosteroid excretion has. 
frequently been reported in depressive illness (Kurland, 1964;
Jakobson e t  a l . ,  1966; Coppen e t  a l . ,  1967a; Butler and Besser, 1968; 
Fullerton e t  a l . ,  1968; Mendels, 1969; Baer e t  a l . ,  1969), the elevation 
occurring more frequently in unipolar than in bipolar depression 
(Dunner e t  a l . , 1972). Urinary 17-hydroxycorticosteroids (17-OHCS) 
have been found to be low (Curtis e t  a l . ,  1960) and normal (Kurland,
1964) in depressive illness and to increase (Stenback et al., 1966) 
and decrease (Gibbons, 1966) with clinical improvement. Bunney and his 
colleagues (1969) reported elevated 17-OHCS levels in subjects who 
subsequently committed suicide or made a serious suicide attempt.
Urinary 17-ketosteroids (17-KS) were raised in depressed patients 
compared with controls (Kurland, 1964; Mendels, 1969) and correlated with 
the severity of the illness (Kurland, 1964). Mendels (1969) discovered 
a greater increase in the ll-oxy-17-KS fraction in eight male 
depressed patients compared with the ll-deoxy-17-KS fraction. There was 
also an increase in urinary androsterone (an ll-deoxy-17-KS) in two of 
the patients compared to control values. The diurnal rhythm of 
corticosteroid excretion has been shown to be abnormal in depressive 
illness (Butler and Besser, 1968; Fullerton et al., 1968).
Cortisol may be elevated in the CSF (Carroll, 1972) but this is 
uncertain (Coppen et al., 1971a).
Corticosteroid secretion rates were found to be elevated during 
the illness (Gibbons, 1964; Sachar et al., 1971a; Carpenter and Bunney,
1971; Sachar et al., 1973a; Sachar, 1975). Sachar (1975) noted active 
secretion of cortisol during the night when secretion is normally 
minimal. The number of secretory episodes over twenty-four hours was 
increased from nine to twelve and the plasma cortisol concentration 
was markedly elevated both at the beginning and end of episodes.
Secretion normalised on recovery (Gibbons, 1964; Gibbons, 1966; Sachar 
et al., 1973a; Sachar, 1975).
In conflict with the above studies, corticosteroids were found to 
be lower in brain tissue of persons who died of suicide compared with 
those who died of other causes (Brooksbanket al., 1972; Brooksbank 
et al., 1973).
Another approach to the study of corticosteroid metabolism in 
depressive illness has been determination of the extent of its suppression 
after dexamethasone administration, Dexamethasone inhibits 
adrenocorticotrophic hormone (ACTH) secretion. Suppression has been 
reported to be normal (Shopsin and Gershon, .1971; Carpenter and Bunney,
1971) and reduced (Butler and Besser, 1968; Carroll and Davies, 1970;
Carroll et al,9 1976; Brown et al., 1979) in endogenous depression.
Brown et al(1980) suggested that the dexamethasone suppression test 
identifies two subgroups of depressed patients each of which responds 
preferentially to a specific type of antidepressant. Resistance to 
dexamethasone suppression also occurs in Cushing's disease (hyperadrenalism) 
(Butler and Besser, 1968) in which depression is a frequent complication 
(Prange et al., 1977).
Checkley and Crammer (1977) examined the corticosteroid response 
to methylamphetamine and found a lower response in depressive illness
than on.recovery. They suggested that their findings may indicate a- 
functional deficiency of noradrenalin at a-adrenergic receptors in 
depressive illness.
Data concerning corticosteroids is difficult to interpret due to 
inadequate control of several factors. For example, corticosteroid 
excretion is in part dependent upon age, sex and body weight (Sachar,
1967). Many of the studies were conducted during the hospital admission 
period when plasma and urinary corticosteroids are elevated (Mason 
et al., 1965). The increase varies according to the type of ward to 
which the patient is admitted: plasma 17-OHCS levels are significantly 
greater in those admitted to a psychiatric ward than in those admitted 
to a metabolic ward (Anderson and Dawson, 1965). The value of the data 
is further reduced by the frequent use of non-hospitalised controls.
Some of the drugs commonly administered to psychiatric patients may 
lead to spurious findings. Barbiturates, used in several of the studies, 
block ACTH secretion at the hypothalamic level, altering the circadian 
rhythm (Krieger and Krieger, 1967) and may also affect the metabolism 
of cortisol (Conney et al* , 1965). Phenothiazines, imipramine and 
desipramine interfere with some of the methods used to determine 17-OHCS, 
resulting in false low readings (Sachar, 1967). Thus the assumption that 
a fall in corticosteroid levels is due to clinical improvement may be 
false if patients are treated with these drugs or if pretreatment levels 
were determined during the hospital admission period. Increased 
adrenocortical activity may therefore be the result of nonspecific 
factors such as the stress of the illness, anxiety or hospitalisation. 
However, this does not provide an adequate explanation for the abnormality 
of dexamethasone suppression which occurs in depressives but not in 
schizophrenics with equivalent psychosis ratings (Carroll, 1976) nor 
for the increased cortisol secretion during the night when both stress
and anxiety are presumably at a minimum.
Increased adrenocortical activity results in reduced serotonin 
synthesis (Curzon, 1969) due to the induction of tryptophan pyrrolase, 
the enzyme catalysing the rate-limiting step in the conversion of 
tryptophan to nicotinic acid. Lack of serotonin is associated with 
reduced sleep (Koella, 1974) and therefore the high morning plasma 
cortisol concentrations observed may be a factor in producing the early 
awakening characteristic of endogenous depression. The conversion of 
noradrenalin to adrenalin is enhanced by corticosteroids due to the 
induction of phenylethanolamine-N-methyl transferase (Harrison et al.,
1968). Hydrocortisone has been shown to increase the noradrenalin 
uptake by rat cerebral cortex (Maas and Mednieks, 1971).
The increased adrenocortical activity may reflect an abnormality 
in the hypothalamic control of pituitary function and the subsequent 
release of ACTH. Mendels et al. (1976) suggested that there may be a 
failure to inhibit the mechanism which normally stops the release of 
corticotrophin releasing factor in depressive illness and that this is 
due to a reduction in activity of noradrenergic neurones which normally 
inhibit ACTH release. If this explanation is correct it would support 
the biogenic amine hypothesis,
(ii) Growth Hormone
A potent stimulus to growth hormone (GH) secretion is a fall in 
blood glucose. There have been several reports of reduced GH response 
to insulin-induced hypoglycaemia in depressive illness (Mueller et al,9 
1969; Sachar et al., 1971b; Sachar et al,9 1973b; Heninger et al.,
1975; Sachar 1975), Patients with unipolar depression were found to
secrete significantly less GH than those with bipolar depression or 
controls in the same age range (Sachar et al., 1973b). However the 
groups were unequally distributed with regard to sex: most of the 
unipolar patients were postmenopausal women. This is of importance 
since GH response is related to circulating oestrogen levels (Sachar,
1975; Gold et al,, 1976), the response being greatest in premenopausal 
women, intermediate in men and lowest in postmenopausal women.
Sachar (1975) studied postmenopausal depressed women and found 
reduced GH responses to insulin-induced hypoglycaemia compared with age- 
matched postmenopausal female controls.
It has been suggested that patients suffering from depressive 
illness are insensitive to insulin and have a reduced rate of glucose 
utilisation (Mueller et al., 1969; Carroll, 1969; Heninger et al.,
1975; Wright et al., 1978). Thus it is possible that the degree of 
hypoglycaemia produced in some studies may have been insufficient to 
cause adequate GH release. Nevertheless in Sacharfs study (1975) the 
hypoglycaemic responses were identical in the two groups both in terms 
of absolute glucose drop and percent drop from the baseline.
L-dopa, the immediate precursor of dopamine, also stimulates GH 
secretion (Boyd et a l . ,  1970; Kansal et a l . ,  1972). Sachar et a l .  (1973b) 
reported lower responses to L-dopa in patients with unipolar depression 
than in those with bipolar depression or controls, but the groups were 
not matched for sex. A later study (Sachar et a l . ,  1975) showed no 
difference between any of the groups. Others have found greater GH 
responses to L-dopa in bipolar depressed patients than in those with 
unipolar depression or controls (Gold et a l . ,  1976; Gold and Goodwin,
1977), The difference between these studies and that of Sachar et a l .  
(1975) was the use of a controlled monoamine diet by the former:
depressives and controls respond differently to a monoaminergic diet 
(Muscettola et al., 1977; Langer and Sachar, 1977). Nevertheless, 
Mendlewicz et al. (1977), using a controlled monoamine diet, found 
that GH responses in patients with bipolar depression were similar 
to those of patients with unipolar depression and to those of controls.
The GH response to hypoglycaemia is mediated by biogenic-amines: 
the response is abolished or inhibited by catecholamine (Frantz et al.,
1973) and serotonin (Bivens et al., 1973) depletors and blockers. The 
GH response to L-dopa is also mediated by biogenic amines (Martin, 1973). 
Sachar (1975) suggested two possible reasons for the abnormal GH 
response of depressed women to hypoglycaemia but not to L-dopa: firstly 
the GH response to L-dopa depends on the brain conversion of exogenous 
amine precursor, while the GH response to hypoglycaemia calls upon 
endogenous brain amines; and secondly the two stimuli may act by 
different neurochemical pathways.
Apomorphine stimulates dopamine receptors directly and does not 
affect noradrenalin receptors or serotonin metabolism (Lai et al,, 1972; 
Frazer, 1975). Administration of apomorphine has been demonstrated to 
stimulate GH release in normal subjects (Lai et al., 1972), Frazer (1975)' 
was unable to find any consistent abnormality in GH response to 
apomorphine in unipolar or bipolar depression, suggesting that dopamine 
is probably not involved in their aetiology.
(iii) Luteinizing Hormone
Plasma luteinizing hormone (LH) concentrations have been found to 
be lower in postmenopausal depressed women than in postmenopausal 
female controls (Altman et al., 1975),
Plasma LH increases postmenopausally due to lack of feedback 
inhibition by oestrogen. This increase can be blocked by catecholamine 
depletors (Ojeda and McCann, 1974). Thus the lower plasma LH in the 
depressed group lends support for the hypothesis of diminished 
noradrenergic activity in depressive illness. Nevertheless, the 
possibility of a difference in oestradiol secretion between the two 
groups cannot be excluded.
The response of LH to LHRH (LH-releasing hormone) has been shown 
to be normal in unipolar depressed men (Ettigi et a l . , 1979).
(iv) Prolactin
Prolactin is involved in lactation but has other functions. It 
promotes renal water, sodium and potassium retention and calcium 
excretion (Horrobin et al., 1976). These authors suggested that 
prolactin may be capable of stimulating sodium movement into erythrocytes 
and an outward movement of some osmotically active solute. Prolactin 
also exerts an effect on progesterone secretion: normal levels stimulate 
progesterone secretion whereas high levels inhibit its secretion 
(Horrobin et a!., 1976; McNeilly, 1980; Veldhuis and Hammond, 1980). 
Veldhuis and Hammond (1980) discovered that oestradiol treatment can 
modify the action of prolactin on progesterone secretion.
Plasma prolactin has been reported to be raised (Sachar et a l . ,  
1973b; Horrobin et a l . ,  1976) and normal (Gold et a l . ,  1976; Cole et a l . ,  
1976; Mendlewicz et a l . ,  1977) in depressive illness. There is a 
circadian rhythm for prolactin in .normal subjects (Nokin et a l . ,  1972; 
Sassin et a l . ,  1972; Osterman and Wide, 1975): serum levels are raised 
during sleep and diminish rapidly just before waking. This rhythm was
shown to be abnormal in depressed patients.(Halbreich e t  al., 1979) 
with increased prolactin levels during the evening, several hours 
before sleep.
Sachar e t  a l .  (1973b) found a normal prolactin response to L-dopa. 
in unipolar and bipolar depression but others have reported suppression 
of prolactin secretion in bipolar depression but not unipolar 
depression (Gold e t - a l . ,.'1976; Gold and Goodwin, 1977; Mendlewicz 
e t  a l . ,  1977).
Prolactin secretion is suppressed by prolactin-inhibiting factor 
(PIF), which increases the activity of dopaminergic neurones (Sachar 
e t  a l . ,  1973b; Horrobin e t  a l . ,  1976), and is elevated by TSH-releasing 
hormone (TRH) and prolactin-releasing hormone (PRH). These excitatory 
factors may be regulated by noradrenergic and/or serotoninergic 
neurones (Horrobin e t  a l . ,  1976).
(v) Thyroid Hormone
Depression is frequently found in hypothyroid patients but not in 
those suffering from hyperthyroidism (Whybrow et al., 1969). Thus it 
is possible that thyroid function may be reduced in depressive illness.
Serum thyroxine (T^) has been reported to be low (Rybakowski and 
Sowinski, 1973; Rinieris e t  a l . ,  1978a) normal (Salvadorini and Saba, 
1973; Amsterdam e t  a l . ,  1979) and high (Kirkegaard e t  a l . ,  197H) in 
depressed patients compared with controls. Free thyroxine index (FTI) 
has also been found to be low (Rybakowski and Sowinski, 1973; Rinieris 
e t  a l . ,  1978a) normal (Salvadorini and Saba, 1973; Kirkegaard e t  a l . ,  
1978a)and high (Whybrow e t  a l . ,  1972; Kirkegaard e t  a l . ,  1974) in
depressive illness? Serum tri-iodothyronine CT3 ) concentrations
(Rybakowski and Sowinski, 1973; Kirkegaard et al.,1978a; Amsterdam
125et al,, 1979) and T3 I uptake (Rinieris et al,, 1978a) were normal 
in depressive illness.
The inconsistencies between these studies may have been due to 
differences in the type and severity of depression. For example,
Kolakowska (1977) stated that raised serum FTI was associated with agitation 
and/or high anxiety and occurred in patients suffering from psychotic 
or recurrent depression. However, Rinieris et al. (1978b) found lower 
FTI values in patients with psychotic depression than in those with 
neurotic depression or controls. There may also have been differences 
in the degree of alcohol abuse of depressed patients which could have 
contributed to the inconsistencies between studies: alcohol abuse 
significantly reduces the FTI (Kolakowska, 1977). .
A reduced response of TSH to TRH has been widely reported in 
depressive illness (Kastin et al., 1972; Prange et al., 1972; Coppen 
et al., 1974; Kirkegaard et al., 1974; Kirkegaard and Smith, 1978;
Kirkegaard et al., 1978a; Mendlewicz et al., 1979; Amsterdam et al.,
1979; Bjorum and Kirkegaard, 1979; Kirkegaard and Bjorum, 1980) but 
this has been disputed (Ettigi et al., 1979), Some investigators found 
a lower response in unipolar than in bipolar depression (Gold et al.,
1977; Gold et al., 1979), but this has also been contradicted (Bjorum 
and Kirkegaard, 1979; Mendlewicz et al,, 1979). The response normalised 
with clinical improvement (Kirkegaard et al., 1974; Kirkegaard and 
Smith, 1978; Kirkegaard and Bjorum, 1980).
The TSH response is influenced by circulating thyroid hormones, 
the response being reduced when circulating thyroid hormone levels 
are raised. This contradicts the hypothesis of reduced thyroid function
in depressive illness. Prange et al. (1977) suggested that the reduced 
TSH response to TRH may be due to a reduction in the releasable pool 
of TSH or to an impairment in the TSH.release mechanism.
(d) Conclusion
The review of the biological studies of depressive illness has 
revealed the abundance of inconsistencies. Hence, despite the vast 
amount of research, the aetiology of the illness remains a mystery.
The main hypothesis is that there is a deficiency of biogenic amine(s) 
in the CNS, but this has so far neither been accepted nor rejected. 
Differences in electrolyte and hormone metabolism could be secondary 
to this proposed abnormality, although changes in these systems can 
produce alterations in biogenic amine metabolism.
Major support for the biogenic amine hypothesis came from the 
effects of antidepressant drugs on amine metabolism (Carlsson, 1976): 
both monoamine oxidase inhibitors (MAOI) and the tricyclics increase 
the amount of physiologically active amine at functionally important 
receptor sites in the brain. The tricyclics inhibit amine reuptake 
into the presynaptic neurone whereas the MAOI prevent amine catabolism, 
but may also inhibit amine reuptake (Hendley and Snyder, 1968; Escobar 
et al., 1974).
The tricyclic compounds are either secondary or tertiary amines.
The tertiary amines (eg. imipramine and amitriptyline) strongly 
inhibit serotonin uptake but are less effective inhibitors of 
noradrenalin uptake. On the other hand, the secondary amines (eg. 
desipramine and nortriptyline) are potent inhibitors of noradrenalin 
uptake but have less effect on serotonin uptake (Carlssoii et al., 1969a,b
Todrick and Tait, 1969; Salama et al.9 1971), Thus there may be a 
subgroup of depressed patients with a disorder of serotonin metabolism 
(Asberg et al., 1976; Goodwin et al.9 1977) and a subgroup with a 
disorder of noradrenalin metabolism (Goodwin et al., 1977; Maas, 1978),
Iprindole, chemically related to the tricyclics and as effective 
an antidepressant as imipramine, has no ability to block amine reuptake 
(Fann et al., 1972). This suggests that tricyclics may exert their 
effect through another mechanism.
Lithium has been shown to increase serotonin biosynthesis (Sheard 
and Aghajanian, 1970; Perez-Cruet et a l . ,  1971), platelet serotonin 
levels (Coppen et a l . ,  1976) and the rate of serotonin transport in vivo 
but not in vitro (Coppen et a l . ,  1980). Lithium has also been shown to 
reduce the rate of disappearance of labelled serotonin from brain 
(Schildkraut et a l . , 1969a) but to increase the rate of disappearance 
of labelled noradrenalin (Schildkraut et a l . ,  1969b).
Although antidepressant drugs appear to increase the amount of amine 
at receptor sites this does not necessarily mean that depression is 
due to an amine deficiency. These drugs may be activating amine systems 
which compensate for a deficit in other systems. The biogenic amine 
hypothesis has been criticised by Baldessarini (1975) as being too 
simple, focusing on only a few amines and considering the amines as 
static father than dynamic systems. Support for the involvement of 
trace amines comes from studies showing that MAOI increase octopamine 
concentrations in brain and heart and elevate levels of octopamine and 
its metabolite p-hydroxy mandelic acid, in urine (Molinoff and Axelrod, 
1972; Kakimoto and Armstrong, 1962). Dietary factors can influence the 
synthesis of neurotransmitters (Fernstrora and Wurtraan, 1974; Growdon 
and Wurtman, 1979; Sahaikian et al., 1979) necessitating more carefully
controlled studies. Also the biogenic amine hypothesis is not 
specific for depression: biogenic amines may play a role in altering 
schizophrenic symptoms (Ashcroft et a l . ,  1966; Bowers et a l . ,  1969; 
Bowers, 1978). '
POSTPARTUM DEPRESSION
Postpartum depression is no longer believed to be a distinct 
condition since Vislie (1956) and Foundeur et al. (1957) demonstrated 
that both the clinical features and prognosis were similar to those of 
endogenous depression. As a result, interest in the concept waned and 
few studies concerned specifically with depressive illness in the 
postpartum period have been carried out. Nevertheless, there is good 
evidence that childbirth is followed by a sharp rise in the incidence 
of depressive illness (Pugh et a l . ,  1963; Paffenberger, 1964; Kendell 
et a l . ,  1976). It has been suggested that 50 percent of women 
experience mild disturbances of mood in the first ten days postpartum 
(Yalom et a l . ,  1968; Pitt, 1968; Pitt, 1973). Estimates of the 
occurrence of depression of sufficient severity to require treatment 
vary. Some investigators have reported an incidence of 3 percent 
within six months postpartum (Ryle, 1961; Tod, 1964) while others have 
found an incidence of 6 percent (Baker et a l , ,  1971), 7 percent (Dalton,
1971) or 11 percent (Pitt, 1968).
It has been suggested that women diagnosed as having an effective 
disorder independent of the postpartum period have an increased risk 
of developing a postpartum affective illness (Bratfos and Haug, 1966; 
Winokur and Ruangtrakool, 1966; Reich and Winokur, 1970), although 
postpartum illnesses appear to occur less frequently in patients with
unipolar affective disorder than in those with bipolar affective 
disorder (Bratfos and Haug, 1966;.Winokur and Ruangtrakool, 1966;. 
Protheroe, 1969; Reich and Winokur, 1970; Baker et al., 1971). It is 
also possible that women suffering from postpartum affective illness 
have an increased risk of later development of non-postpartum affective 
illness (Thornton, 1977; Uddenberg and Engelsson, 1978).
The aetiology of the disorder is unknown, but as with endogenous 
depression genetic factors have been suggested to be involved (Thuwe,
1974). Several theories have been put forward concerning the biochemical 
abnormality responsible for the illness, the role of the dramatic 
hormonal changes that occur in the few days after childbirth and with 
the onset of lactation being a recurrent theme. The main hypotheses 
concern progesterone (Malleson, 1953; Yalom et al,, 1968; Dalton, 1971; 
Welburn, 1980): plasma progesterone levels before delivery may be 
excessively high in women who develop affective illness; the rate of 
fall after delivery may be too fast; or there may be an abnormal ratio 
of oestrogen to progesterone. Other hypotheses relate the affective 
illness to low corticosteroid levels (Bower and Altschule, 1956), to 
prolactin release (Oppenheim, 1962) and to abnormalities in thyroid 
function (Ballarchy et al., 1958). Nott et al. (1976) measured plasma 
LH, FSH (follicle stimulating hormone), total oestrogen, progesterone 
and prolactin in pregnant women before parturition and on sixteen days 
in the six weeks following delivery, but failed to produce any strong 
evidence that hormones are related to mood at this time. However, the 
emotional disturbances reported were neither severe nor prolonged.
Stein et al. (1976) measured free and total plasma tryptophan on 
the sixth day postpartum in eighteen women. Those with severe depression 
were found to have significantly reduced concentrations of free tryptophan. 
Values were similar to those of patients suffering from endogenous
depression and correlated negatively with the severity of the illness. 
Handley et al. (1977) studied free and total tryptophan and cortisol 
in the plasma of eighteen women, daily from day two to five postpartum. 
Over this period plasma free tryptophan concentrations tended to rise 
and plasma cortisol concentrations to decline. There was a positive 
correlation between plasma free tryptophan concentrations and elevation 
of mood and a negative correlation with depression. Plasma cortisol 
concentrations also correlated positively with elation, but there was 
no significant correlation between cortisol and either free or total 
tryptophan concentrations. Reduced concentrations of plasma free 
tryptophan may result in decreased brain serotonin synthesis (Fernstrom 
and Wurtman, 1971; Knott and Curzon, 1972; Tagliamonte et al., 1973), 
but this is uncertain (Fernstrom et al., 1976; Wiryanti, 1980).
Vitamin Bg is an essential cofactor for the decarboxylase involved 
in the formation of serotonin from tryptophan (Buxton and Sinclair,
1956) and hence a deficiency of vitamin Bg might contribute to the 
production of postpartum depression. Although vitamin Bg deficiency 
is associated with 'the depression occurring in pregnant women (Pulkkinen 
et al.9 1978) and in those using oral contraceptives (Adams et al.,
1973; Wynn, 1975; Drug and Therapeutics Bulletin, 1978; Donald and 
Bosse, 1979; Bosse and Donald, 1979), Livingston et al. (1978) found 
no evidence of vitamin Bg deficiency in women suffering from postpartum 
depression. Thornton (1977) described, a case history of depression in 
the postpartum period which was due to folic acid deficiency. This is 
of interest since a deficiency of folic acid may also reduce the 
formation of serotonin (Botez et al., 1979).
Ballinger et al. (1979) measured twenty-four hour urinary excretion 
of cyclic AMP (adenosine 3f5f cyclic monophosphate) in a group of women 
on two occasions in the week following childbirth and again two to three
months later. Cyclic AMP concentrations were higher in the week 
following childbirth than two to three months later. Those women 
showing the most emotional disturbance on the third day after delivery 
and women indicating most mood change in the direction of becoming 
elated had the highest levels of cyclic AMP excretion on that day.
This is in agreement with previous work in mania and depression 
(Abdullah and Hamadah, 1970).
In conclusion, it appears that biochemical abnormalities in women 
with postpartum depression are similar to those in patients with 
endogenous depression. In addition, envrionmental factors may play a 
role in the genesis of depressive illness in some postpartum women 
(Weiburn, 1980).
BACKGROUND TO THE PRESENT STUDY
In the normal healthy mammal, there are two major series of long 
chain polyunsaturated fatty acids (LCP) derived from two short chain
JL
polyunsaturated fatty acids (SCP), linoleic acid (18;2w6) and 
a-linolenic acid (18:3w3). These two parent fatty acids cannot be 
synthesised denovo (Holman, 1970a,b; Brenner, 1974) and are therefore 
obtained from the diet. Linoleic acid gives rise to the u)6 series of 
fatty acids: y-dihomolinolenic acid (2Q:3u)6) and arachidonic acid 
(20:4oj6) and a-linolenic acid gives rise to the w3 series:
jk ■
Fatty acid nomenclature as follows: the number before the colon 
represents the number of carbon atoms. The number after the colon 
represents the number of cis double bonds. The number following 
the omega represents the position of the first double bond measured 
from the methyl end of the molecule, It is assumed that all of 
the double bonds are methylene interrupted.
eicosapentaenoic acid (2Q;5w3) and docosahexaenoic acid (22;6«3)
(see Figure 5). Interconversion between the two series does not 
appear to occur (Holman, 1970a,b). In addition to these two series 
there is a third series of LCP, the w9 series, derived from oleic 
acid (18:lw9) (see Figure 5) which can be synthesised de novo.
These pathways were elucidated in the rat by several groups of 
investigators using a combination of radioisotope techniques and gas- 
liquid chromatography (Steinberg et al., 1957; Fulco and Mead, 1959; 
Klenk and Mohrhauer, 1960; Mead, 1961).
Competitive inhibition occurs between fatty acids for the chain 
elongating and desaturating enzyme systems (Brenner and Peluffo, 1966; 
Alfin-Slater and Aftergood, 1968; Brenner, 1974). For any given chain 
length the more unsaturated the fatty acid the greater is its affinity 
for the enzyme system. Hence 18:3w3 is desaturated in preference to 
18:2w6 which is desaturated in preference to 18:lw9, Increasing the 
relative proportion of the less unsaturated fatty acid will reverse 
the preference, for example when the concentration of 18;2w6 is high 
relative to that of 18:3to3, 18:2a)6 is desaturated in preference to 
18:3w3. Also there is some evidence that LCP can inhibit their own 
production from SCP: both 22:6w3 (Brenner and Peluffo, 1967; 
Christiansen et al,, 1968; Actis Dato and Brenner, 1970) and 22:5w6 
(Actis Dato and Brenner, 1970) can inhibit their own production from 
18:3m3 and 18:2a)6 respectively.
The rate-limiting step in the synthesis of LCP is the first
desaturation, catalysed by A6 desaturase. This enzyme requires CoA
2+(Coenzyme A), ATP (adenosine triphosphate), Mg and NADH (Brenner 
and Peluffo, 1966; 1969; Castuma et al.9 1972; Cook, 1978)
and a protein factor, as yet unidentified (Catala et al., 1975; Catala 
et al. 9 1977). A6 desaturase activity is affected by a number of
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dietary and hormonal factors (Brenner, 1974; Brenner, 1977) which 
will be discussed in more detail in Chapter 6 ,.
,1 .■
LCP can also be obtained directly from the diet as they are 
present in animal products (Crawford and Sinclair, 1972; Paul and 
Southgate, 1978).
The brain contains considerable amounts of LCP (mainly 20:4w6 and 
22:6w3) which are either derived from in situ conversion of 18:2u5 
and 18:3w3 respectively (Mead et al., 1977) or arrive at the brain as preformed
compounds (Galli et al., 1977). Fatty acids produced in the liver ' V
1
can be transported to the brain via the plasma, 18;2w6 and 18:3w3 
being transported preferentially as free fatty acids (Dhopeshwarkar and 
Mead, 1973) and LCP being transported primarily in the choline 
phosphoglycerides (Ansell and Spanner, 1972; Sinclair, 1975; Crawford 
et al., 1976).
Little is known about the function of LCP. In the brain they are
associated with membrane phospholipids (Cotman et al., 1969) and hence
may affect membrane function. Changes in the fatty acid composition of
structural lipids in brain membranes have been reported to modify 
H" *f"
Na-K-ATPase activity in synaptosomes (Sun and Sun, 1976) and « 6  and m3
fatty acids are considered important for the activity of some other 
membrane-bound enzymes (Bernsohn ‘and Spitz, 1974). Moreover, alterations 
in the fatty acid composition of membrane lipids affect the permeability 
of the membrane (van Deenan, 1971; McElhaney, 1974).
LCP are also important functional components of the photoreceptor 
membranes of the retina, 22:6w3 being the predominant fatty acid of the 
rod outer segments (Anderson and Maude, 1970; Borggreven et al., 1970;
Nielson et al., 1970). When the content of LCP is reduced, there is an
alteration in the electrical response of the photoreceptor membranes 
(Benolken e t  a l . ,  1973; Wheeler e t  al,, 1975; Anderson e t  a l . ,  1977).
The m3 series affect electroretinogram amplitudes to a greater extent than 
the w6 series, indicating a selective functional role in the visual 
system for to3 fatty acids.
When rats (Holman, 1970a,b) human infants (Soderhjelm e t  a l . ,  1970) 
or adults (Collins e t  a l . ,  1971; Holman, 1973) consume a fat-free diet 
they develop a generalised scaliness of the skin which can only be 
reversed by 18:2w6 or its metabolite 20:4w6. Thus 18:2w6 is said to be 
an essential fatty acid (EFA). Diets deficient in 18:2w6 and 18:3w3 
(Paoletti and Galli, 1972; Galli e t  a l . ,  1975a,b; Lamptey and Walker,
1978), or diets with different 18:2w6/18:3w3 ratios (Lamptey and Walker, 
1976) produce modifications in the learning behaviour of animals.
Some LCP (20:3uj6, 20:4gj6, and 20:5to3) are precursors of biologically 
active substances, the prostaglandins and related compounds (Alfin-Slater 
and Aftergood, 1968; Galli et a l . ,  1977; Galli et a l . ,  1978). The system 
which forms prostaglandins from 20:4to6 has been extensively studied in 
several laboratories. The formation of an endoperoxide intermediate in 
the synthesis of prostaglandins and thromboxanes has been described by 
Hamberg and Samuelsson (1973; 1974). The-rate-limiting step in the 
overall formation of active products from 20:4w6 is the release of the 
precursor from phospholipids (Horton, 1975; Flower and Blackwell, 1976). 
This step involves activation of a phospholipase acting on the 2 
position of the phosphoglycerides. It is not known whether a specific 
phospholipid is the donor of 20:4w6 for prostaglandin synthesis, although 
release of 20:4w6 mainly from phosphatidyl inositol has been reported 
in stimulated platelets (Schoene and Iacono, 1976; Bills et a l . ,  1976). 
Within the CNS, prostaglandins alter the effects of neurotransmitters 
at pre- and postsynaptic sites (Horton, 1973; Hedqvist, 1974; Hedqvist,
1976; Craig, 1976).
The plasma choline phosphoglycerides (CPG) account for 70 percent 
of the total plasma phospholipids in man (Phillips and Dodge, 1967) and 
have been shown to be good indicators of polyunsaturated fatty acid 
status (Rivers et al,, 1975). Nevertheless, the fatty acid composition 
of the erythrocyte phospholipids probably gives a better indication of 
tissue polyunsaturated fatty acid status (Sanders and Naismith, 1979).
The lipids of erythrocytes are confined to the membrane (Cooper, 
1970). In human red cells the major lipids are cholesterol and the 
phospholipids. There are four main phospholipids, each having its own 
characteristic fatty acid composition. The ethanolamine (EPG) and 
serine phosphoglycerides (SPG) contain large amounts of LCP, the choline 
phosphoglycerides (CPG) contain lesser amounts of LCP and greater 
amounts of 18:2a)6 and short chain saturated fatty acids and the 
sphingomyelin fraction contains considerable amounts of long chain 
saturated (23:0 and 24:0) and monounsaturated (24:1) fatty acids (Dodge 
and Phillips, 1967). The chemical structures of these phospholipids 
are shown in Figure 6 . The R* position in.the phosphoglycerides is 
almost invariably occupied by saturated fatty acids whereas the RM 
position contains all the C^g, C^q and C ^  polyunsaturated fatty acids 
(Christie, 1973). The R* position occassionally contains a vinyl ether 
(plasmalogen) residue (Farquhar, 1962; Christie, 1973). The EPG, which 
constitute about 30 percent of the erythrocyte phospholipids (Dodge and 
Phillips, 1967), have been used as indicators of LCP status (Crawford 
and Sinclair, 1972).
A preliminary study of six patients suffering from endogenous 
depression (Ellis and Sanders, 1977) revealed that there was a higher 
proportion of LCP, in particular 22:6tu3 and 20:5w3, in their plasma 
CPG than in those of age-sex-matched controls or patients suffering
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from other psychiatric disorders. Differences in the erythrocyte EPG 
were in the same direction but were not significant. The present study 
was undertaken to repeat and to extend these investigations, since it 
is possible that a higher proportion of LCP may affect membrane function 
(van Deenan, 1971; McElhaney, 1974; Lenaz, 1979) and hence help to 
explain the proposed abnormality in membrane transport of cations (Mendels 
and Frazer, 1973; Mendels and Frazer, 1974; Hesketh et a l . ,  1977; Choi 
et a l . ,  1977) and serotonin (Coppen et a l . ,  1978; Coppen et a l , ,  1980) in 
some patients with depressive illness.
There were only a few other studies in the literature concerning 
lipid metabolism in patients with depressive illness. Total serum lipids 
have been reported to be low in depressed patients (Shaheen et a l . ,  1971) 
due to their disturbed appetite and to increase (Shaheen et a l . ,  1971) 
and decrease (Hullin and Court, 1970) on recovery. Serum triglyceride 
concentrations were also found to be low in patients suffering from 
endogenous depression but to decrease further with clinical improvement 
(Shaheen et a l , , 1971). Three possible reasons for this were suggested: 
disturbed synthesis of triglycerides; inhibition of lipogenesis; and/or 
disturbed transmethylation processes. Finally, plasma free fatty acid 
concentrations have been shown to be raised in depressed patients (Cardon 
and Mueller, 1966; Mueller et a l . ,  1970). Mueller et a l ,  suggested that 
this may be related to the reduced glucose utilisation of depressed 
patients.
AIMS OF THE PRESENT STUDY
The present study was undertaken in order to repeat and extend the 
investigations of Ellis and Sanders (1977) as these related to only
six patients.
The aims were as follows:
1) To ascertain whether determination of the LCP composition of the
plasma CPG would be of value as a diagnostic tool for endogenous 
depression.
2) To ascertain whether the'higher LCP concentrations are reflected in 
the erythrocyte membrane phospholipids.
3) To discover if the LCP concentrations return to normal with clinical 
improvement.
4) To determine whether the abnormality occurs in postpartum depression
5) To ascertain whether the use of oral contraceptive agents affects
phospholipid LCP composition.
6 ) To examine factors affecting the LCP composition of the plasma CPG, 
in order to discover the aetiology of the observed differences.
CHAPTER TWO
SUBJECTS, MATERIALS AND METHODS.
SUBJECTS
Patients suffering from depressive illness or from other psychiatric 
disorders were in-patients at Kingston Hospital. Patients with early 
symptoms of depressive illness were contacted through general 
practitioners (Drs. J. Kane and J. Boxer, 11 Birkenhead Avenue, Kingston 
upon Thames). Control subjects were apparently healthy hospital staff, 
their relatives and friends and were matched to the patients by age and 
sex. .■■■.'•
BLOOD SAMPLES
Blood samples were taken by venepuncture with stasis at 9,30 a.m. 
after an overnight fast and sent to the laboratory immediately. Serum 
was used for the estimation of thyroid function and fasting insulin 
concentrations but for other analyses blood was anticoagulated with 
trisodium ethylenediamine tetraacetate (EDTA). Samples were analysed 
•blind1 i.e. the diagnoses and other details of the patients were known 
only to the psychiatrist until after the results were obtained.
CHEMICALS
Most of the chemicals used were purchased from BDH Chemicals Ltd. 
(Poole, Dorset) and were Analar grade. Toluene was Aristar grade. 
Standards for thin-layer chromatography (TLC) were obtained from Sigma 
Chemical Company (Poole, Dorset), and those for gas-liquid chromatography 
(GLC) from Sigma Chemical Company, Field Instruments (Twickenham, 
Middlesex), N.E.N. Chemicals (Dyson Instruments, Newton Hall, Durham),
Uniscience Ltd. (Cambridge) and Nu-Chek Prep (Elysian, Minnesota,
U.S.A.). Packing materials for GLC columns were purchased from the 
following firms: Silar 10CP (100%-3-cyanopropyl silicone) coated on 
chromasorb W AW/DMCS, 100-120 mesh, from NiE.N. Chemicals; 10% EGSS-Y 
coated on chromasorb W AW/DMCS, 100-120 mesh, from Perkin-Elmer Ltd.
(Beaconsfield, Bucks). -.,y
ANALYTICAL METHODS
General Precautions Taken in Lipid Analyses
Plastic apparatus and containers other than teflon were avoided. 
Analyses (except the preparation of methyl esters) were carried out in 
all-glass apparatus. Methyl esters were prepared in glass tubes with 
teflon-lined screw caps. Glassware was cleaned by soaking in chromic 
acid for at least 24 hours, rinsed thoroughly in tap water, twice in 
distilled water and finally dired in an over prior to use. Teflon-lined 
screw caps were cleaned by boiling in methanol.
In order to minimise auto-oxidation of polyunsaturated fatty acids 
(Dodge and Phillips, 1966) the antioxidant 2, 6 -di-tert-butyl-p-cresol 
(butylated hydroxytoluene, BHT) was added at a level of 50mg/l to all 
solvents and spray reagents, except hexane (Christie, 197-3) and 500mg/l 
to all TLC solvents (Dodge and Phillips, 1967), BET was twice 
recrystallised from methanol prior to use.
Lipid extracts were stored in chloroform under nitrogen at -20°C 
and methyl esters in hexane under nitrogen at -20°C. Solvents were 
evaporated prior to TLC or GLC using a stream of nitrogen and TLC plates 
were also dried with nitrogen.
Blood was chilled to 4°C and then centrifuged at 3,000 g for ten 
minutes. Plasma was removed and stored at -20°C. Under these conditions
there is no alteration in the fatty acid composition of the choline 
phosphoglycerides for at least a year (Sanders, 1977). Erythrocyte 
lipids were extracted immediately.
Preparation of Lipid Extracts
(a) Erythrocytes
The residual packed cells were washed three times with an equal 
volume of 0.15 M (8.9 g/1) saline, centrifuged and the supernatant and 
buffy coat discarded.
Erythrocyte lipids were extracted using chloroform-isopropanol 
7:11 (v/v) (Rose and Ocklander, 1965) for subsequent fatty acid and aldehyde 
analysis or using chloroform-methanol 1:1 (v/v) (Dodge and Phillips, 1967) 
for subsequent lipid phosphorus and free cholesterol determinations. The 
chloroform-isopropanol procedure is better suited for the preparation of 
an extract for fatty acid and aldehyde analysis-since it uses much 
smaller volumes of solvent thereby reducing the possibility of contamination 
of the sample, whereas the chloroform-methanol extraction is preferred when 
lipid phosphorus is to be determined since inorganic phosphorus is not 
removed by the former method (Sanders, 1977).
(b) Plasma
Plasma lipids were extracted as described by Folch, Lees and Sloane- 
Stanley (1957) using chloroform-methanol .2:1 (v/v) and finally washing 
the extract with one-fifth its volume of water containing 0.29% sodium 
chloride in order to remove non-lipid contaminants.
Isolation and Separation of Phospholipids
Phospholipids were isolated from other lipids and then separated into
individual phospholipid classes by TLC on a 0.5mm layer. of silica gel HR.
TLC plates were prepared with water (neutral plates): 90 mis to 40g 
silica gel, and the slurry applied to 2 0  x 2 0  cm glass plated using the 
Unoplan spreader and plate leveller (Shandon Southern Instruments,
Camberley, Surrey). After spreading the gel was allowed to dry 
horizontally in air until the sheen on the surface was replaced by a dull 
matt appearance (approximately one hour). The plates were then activated 
by heating at 110°C for one hour. Unused plates were reactivated in the 
same manner prior to use.
Lipid extracts were dried under nitrogen and then redissolved in a 
small volume of chloroform. An equivalent of 0.5 ml of plasma or packed
red cells was applied to the plate as a 2cm band, 1.5 - 2 cm from the
bottom. The plate was then developed with acetone-hexane 1:3 (v/v) at 
4°C (Skipski and Barclay, 1969), The chromatography tank was lined with 
blotting paper which dipped into the solvent. This produced a solvent- 
saturated atmosphere inside the tank which helped to maintain reproducibility 
from plate to plate, assisted even running and helped to increase the speed
of running. In this solvent system the phospholipids remained at the
origin whereas less polar neutral lipids such as cholesterol and the 
triglycerides migrated up the plate. When the solvent reached the top 
(J - 5 hour), the plate was dried under nitrogen and redeveloped in the 
same direction with chloroform-methanol-acetic acid-water, 25:15:4:2 (v/v) 
(Skipski, Peterson and Barclay, 1964) under conditions of tank saturation 
at 4°C as above. This system separated the individual phospholipids.
The plate was removed from the tank when the solvent front was about 2 cm 
from the top, dried under nitrogen and then sprayed with 2f7f- 
dichlorofluorescein reagent (0.1% solution in 95% methanol and washed with 
hexane (Parker and Peterson, 1965) before use). Bands were visualised 
under ultraviolet light and indi.vidual phospholipids identified by comparison
of their migration with authentic standards.
Determination of the Phospholipid Fatty Acid and Aldehyde Composition
(i) Preparation of Methyl Esters and Dimethyl Acetals
Bands pertaining to the individual phospholipids were circled with 
a fine needle and each transferred to a centrifuge tube fitted vrith a 
teflon-lined screw cap. 1  ml of methanol was added followed by 1  ml of 
14% w/v boron trifluoride in methanol. The tubes were flushed with 
nitrogen, sealed and heated at 100°C for time periods specified by 
Morrison and Smith (1964), .
(ii) Extraction of Methyl Esters and Dimethyl Acetals
(a) Plasma - Having allowed the tubes to cool to room temperature, 4 mis of 
hexane were added followed by 2 mis of water. The tubes were then mixed 
thoroughly and centrifuged: the 2,7,-dichlorofluorescein dye remained in 
the lower aqueous phase. The upper phase containing the methyl esters
was collected and stored under nitrogen at -20°C.
(b) Erythrocytes - 4 mis of hexane were added followed by 2 mis of 5M 
sodium hydroxide, dropwise with stirring, at 0°C. After thorough mixing 
the tubes were centrifuged and the upper phase containing the methyl esters 
and dimethyl acetals collected. The base was added to prevent reversion
of the dimethyl acetals (Morrison and Smith, 1964). A second extraction 
with 2 mis of hexane was carried out to ensure recovery of the dimethyl 
acetals. This was pooled with the first and stored under nitrogen at -20°C
(iii) Purification of Methyl Esters and Dimethyl Acetals
This was carried out by TLC on a 0.5 mm layer of silica gel G. Samples 
were dried under nitrogen, redissolved in 50 yl of hexane and applied to
the plate as bands. The plate was developed with toluene at 4°C (Dodge
and Phillips, 1967). After drying the plate under nitrogen, bands were
located by spraying with 0 .1 % dichlorofluorescein reagent and visualised j
in ultraviolet light. Methyl esters and dimethyl acetals were identified 
by comparison of their migration with authentic standards. The relevant 
bands were then removed from the plate and transferred to a glass- 
stoppered centrifuge tube. Elution from the gel by 2 mis of methanol 
containing 1% acetic acid (Dudley and Anderson, 1975) was followed by a 
hexane and water extraction. After centrifugation the upper phase was removed
and stored under nitrogen at -20°C.
: \ '/M ' .. ' . 1
(iv) Analysis of Methyl Esters and Dimethyl Acetals
Samples were dried over anhydrous sodium sulphate and the hexane 
evaporated under nitrogen. Methyl esters and dimethyl acetals were then 
taken up in 50 yl of hexane and analysed by GLC on a Perkin Elmer Fll 
gas chromatograph fitted with dual flame ionisation detectors and 
recorded on a Perkin Elmer 159 recorder. Analyses were carried out using 
a 2 m x 7 mm o.d..all glass column packed with 10% Silar 10CP on 
chromosorb W AW/DMCS 100-120 mesh at 190°C with a nitrogen flow of 50 mis/min 
and confirmed on a similar column packed with 10% EGSS-Y on chromosorb 
W AW/DMCS 100-120 mesh at 190°C with a nitrogen flow of 25 mls/min.
Methyl esters were identified by comparison of their retention characteristics 
with those of authentic standards and secondary reference standards 
(Ackman and Burgher, 1965). Components were quantified by taking the 
retention time multiplied by the peak height as proportional to the weight 
of the component, (Christie, 1973), and the results expressed in mg/g 
total.fatty acid methyl esters detected. Quanitification was checked 
regularly using authentic standards of known composition.
One blood sample was taken through the whole procedure six times 
and coefficients of variation calculated for each fatty acid of all 
phospholipids analysed to establish the precision of the methods 
(Tables 2-4). Thereafter all analyses were carried out in duplicate.
These methods have previously been examined in detail (Sanders, 1977) 
and will not be discussed further here.
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Determination of Total Plasma Choline Phosphoglycerides (Lecithin)
To determine total plasma lecithin an internal standard (50 pg of 
pentadecanoic acid, C15:0) was added at the stage of preparation of 
methyl esters of plasma choline phosphoglyceride fatty acids (Christie 
et al., 1970). Total plasma lecithin was then calculated in the following 
way:
Total 'Area'
Total Lecithin = 'Area* of C15:0 x 100 x 1.371 (mg/1)
The coefficient of variation (c.o.v.) was 4.6%. The recovery of standard 
lecithin was (mean ± S.E.) 90.3 ±2.8%.
Determination of Total Lipid Phosphorus and the Relative Proportions of 
Phospholipids in Erythrocytes
Aliquots of the total erythrocyte lipid extract were digested with 
0.4 ml of 70% perchloric acid and phosphorus determined in triplicate 
using a modification of the method of Bartlett (1959) as described by 
Dittmer and Wells (1969). Optical density was measured in a Unicam 
SP-600 spectrophotometer at 830 nm. The standard curve is shown in 
Figure 7, The coefficient of variation was 5.4%.
To determine the relative proportions of phospholipids in the 
erythrocytes,phospholipids were separated by TLC as described above, the 
relevant bands removed from the plate and digested with 1 ml of 70% 
perchloric acid. The larger amount of perchloric acid was required to 
ensure sufficient acidity of the reaction mixture as perchloric acid is 
neutralised by silica gel: insufficient acidity results in artifactually 
increased absorption (Dodge and Phillips, 1967). The phosphorus content 
of each band was determined and expressed as a percentage of the total 
phosphorus after TLC (max c.o.v. 5.2%). The recovery of phosphorus
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(mean ± S.E.) was 86.1 ±3.4%.
Determination of Total and Free Cholesterol
Total plasma cholesterol was estimated by the ferric chloride - 
sulphuric acid reaction as described by Tietz (1976). Optical density 
was measured in a Unicam SP-600 spectrophotometer at 560 nm. The standard 
curve is shown in Figure 8 . The coefficient of variation was 2.8%.
The ratio of free:esterified cholesterol in plasma was determined 
in the following way: free and esterified cholesterol were separated by 
TLC of the plasma lipid extract using hexane - diethyl ether - glacial 
acetic acid, 80:20:1 (v/v) as the developing solvent. Bands were located 
using iodine vapour and identified by comparison of their migration with 
authentic standards. Bands corresponding to free cholesterol and to 
esterified cholesterol were removed from the plate, extracted once with 
2 mis of chloroform and three times with 1 ml of chloroform (Dodge and 
Phillips, 1967). The solvent was then evaporated to dryness under 
nitrogen and the cholesterol content of each band determined by the ferric 
chloride - sulphuric acid reaction. Free and esterified cholesterol were 
expressed as a percentage of the total cholesterol after TLC (max. c.o.v. 
3.5%).
BHT was not added to any of the solvents used for the determination 
of the relative proportions of free and esterified cholesterol in plasma 
as it interferes with the ferric chloride - sulphuric acid reaction, 
producing a brownish product that absorbs at 560 nm (Dodge and Phillips, 
1967).
Erythrocyte free cholesterol was determined in the same way as the 
plasma free cholesterol. The coefficient of variation was 4,3%. The 
presence of BHT in the lipid extract was not a problem as in the solvent
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system used it migrates just behind the cholesterol esters but with 
considerable overlap (Dodge and Phillips, 1967). Free cholesterol 
standards were subjected to TLC and the standard curve drawn from their 
optical densities after TLC, thereby making correction for recovery 
from the plate unnecessary. Recovery of the standards (mean ± S.E.) was 
90.2 ±2.5%.
ANCILLIARY INVESTIGATIONS
Blood counts were determined on a Coulter model S senior counter 
and blood films examined by the duty haematologist. Plasma viscosity was 
measured using a Coulter Viscometer (Harkness type). Thyroid function 
and fasting serum insulin were determined by radioimmunoassay techniques 
in use at Kingston Hospital and St. Luke*s Hospital, Guildford, 
respectively. Blood glucose was estimated by an enzymic method (glucose 
oxidase) in use at Kingston Hospital. Plasma 17-3-oestradiol was 
determined by radioramunoassay using the kit supplied by Serono U.K. Ltd. 
(Welwyn Garden City, Herts). The standard curve is shown in Figure 9. 
Plasma cyclic AMP (cyclic 3f5*-adenosine monophosphate) was determined 
by the radioimmunoassay technique described by Tovey et al, (1974)
("Cyclic AMP Assay Kit", Radiochemical Centre, Amersham). The standard 
curve is shown in Figure 10. Dietary information was collected by 24-hour 
recall and by dietary history (Mann-et al., 1962).
STATISTICAL METHODS
The two-tailed student t-test was used for testing differences between 
means when samples were not paired. When samples were paired, either 
Wilcoxan’s test for pair differences or a two-tailed paired sample t-test 
was used. Differences in the frequency of certain observations between
groups were tested using a XZ 2 x 2  contingency table. The correlation 
coefficient (r) used was the coefficient of product-moment correlation. 
Statistical tests were performed as described by Campbell (1975). A 
value of p < 0.05 was taken to indicate statistical significance.
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CHAPTER THREE
SOME BLOOD LIPID MEASUREMENTS IN PATIENTS SUFFERING FROM DEPRESSIVE 
ILLNESS AND IN PATIENTS WITH OTHER PSYCHIATRIC DISORDERS
Introduction
Erythrocyte membranes contain lipids (mainly cholesterol and 
phospholipids), proteins and carbohydrates. The latter are minor 
components and are usually bound to lipids, forming glycolipids or to 
proteins, forming glycoproteins. The lipid components are responsible 
for the structural integrity of the membrance (Lodish and Rothman, 1979). 
Each lipid molecule is amphipathic, that is one part is hydrophilic and 
another part is hydrophobic. The fatty acid substituents of the 
phospholipids are hydrophobic whereas the region containing the phosphate 
and amino, groups is hydrophilic. The hydrophilic group in cholesterol 
is the hydroxyl group. Because the two parts of the molecule have 
incompatible solubilities the membrane is thought to be organised in the 
form of a bilayer, the two hydrophilic surfaces separated by a hydrophobic 
core (see figure 11). The bilayer is not static: the molecules are free 
to diffuse laterally within each monolayer but movement from one 
monolayer to the other (flip-flop) is rare (Lodish and Rothman, 1979).
This concept of membrane structure was proposed by Danielli and Davson 
(1935) and has been both criticised (Korn, 1956) and defended (Stoekenius 
and Engelman, 1969). The theory is therefore viewed as possible but not 
established.
Alterations in the composition of the membrane affect its function. 
Changes in the fatty acid composition of membrane lipids affect the 
permeability of the membrane (van Deenan, 1971; McElhaney, 1974; Lenaz, 
1979) and the activity of certain membrane-bound enzymes (Bernsohn and 
Spitz, 1974; Sun and Sun, 1976; Lenaz, 1979). The relative amounts of the
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various phospholipids can also influence the permeability of the membrane 
(Cooper e t  a l . ,  1977) and affect the activity of some membrane-bound 
enzymes (Kimelberg and Papahadjopoulos, 1972; Coleman, 1973; Cooper 
e t  a l . ,  1977). The ratio of cholesterol:phospholipid is another important 
determinant of membrane function (Cooper, 1970; Vanderkooi e t  a l . ,  1974; 
Cooper e t  a l . ,  1975; Shinitzky and Inbar, 1976; Cooper, 1978; Cooper e t  a l .  
1978; Lenaz, 1979). These factors were investigated in patients suffering 
from depressive illness and in those suffering from other psychiatric 
disorders.
Patients
Twenty-six patients suffering from endogenous depression, twenty- 
three patients suffering from reactive depression, six patients suffering 
from postpartum depression, eleven patients suffering from other 
psychiatric disorders and age-sex-matched apparently healthy controls 
were studied. Of the patients suffering from endogenous depression, seven 
were bipolar and nineteen were unipolar. The mean age was 52 years, 
ranging from 21 to 74 years. The mean age of patients with reactive 
depression was 38 years, ranging from 22 to 65 years. Of the patients 
suffering from postpartum depression, three had given birth to their first 
baby and three to their second baby; the mean length of time postpartum 
was 20 weeks, ranging from 8 to 32 weeks. The mean age of these patients 
was 30 years, ranging from 25 to 34 years. Of the patients with other 
psychiatric disorders, six were schizophrenics and five had personality 
disorders. The mean age was 35 years, ranging from 19 to 59 years. The 
ages of the controls were ±5 years those of the patients, although most 
were' ±2 years. Patients suffering from postpartum depression were also 
matched for parity and length of time postpartum. All the patients and 
controls were Caucasian.
Diagnosis of endogenous or reactive depression was based on the 
clinical interview: patients of doubtful classification were excluded 
from the study. The severity of depression was assessed by the Beck 
Inventory (Beck et al., 1961). ^
Fourteen of the patients suffering from endogenous depression (54 
percent), fifteen of the patients suffering from reactive depression (65 
percent), four of the patients suffering from postpartum depression (67 
percent) and five of the other psychiatric patients (46 percent) were 
drug-free for at least two weeks before the study. The remainder were 
receiving a hypnotic and/or a tranquilliser. Two of the schizophrenic 
patients were receiving a neuroleptic. There was no difference in the 
phospholipid fatty acid composition of patients taking these drugs 
compared with drug-free patients in the same group.
RESULTS
(a) Studies of Patients Suffering from Endogenous Depression, Reactive 
Depression and Other Psychiatric Disorders
The plasma CPG of patients suffering from endogenous depression 
(Table 5) contained a higher proportion of LCP (p < 0.001), in particular 
22:6w3 (p < 0.001) and 20:5o)3 (p < 0.05) and a reduced proportion of 
18:2i»)6 (p < 0.001) compared with those of age-sex-matched controls. The 
plasma CPG fatty acid composition of patients with reactive depression 
(Table 6 ) and of those with other psychiatric disorders (Table 7) did not 
differ from those of matched controls.
Of the patients suffering from endogenous depression, 81 percent 
had a 22:6oj3 concentration of more than 54 mg/g total fatty acid methyl 
esters detected compared with only 19 percent of matched controls and a
jfe
See Appendix
similar proportion of patients with reactive depression or with other 
psychiatric disorders (Table 8 ). Regarding the total LCP, 69 percent 
of the patients suffering from endogenous depression had a concentration 
of more than 244 mg/g total fatty acid methyl esters detected (Table 8 ) 
compared with only about 2 0  percent of matched controls and of patients 
in other groups.
In the endogenous group, six of the patients were referred from 
general practitioners before beginning treatment. These patients had 
similar LCP concentrations to those of in-patients suffering from 
endogenous depression (Table 9), indicating that the abnormality was 
present in the early stages of the illness.
The Beck Inventory scores of fifteen patients suffering from 
endogenous depression and of fifteen patients suffering from reactive 
depression (Figure 12) revealed that the severity of depression was 
similar in both groups. The 22:6w3 concentrations in the plasma CPG of 
patients with endogenous depression correlated with the severity of the 
illness (Figure 13, r = 0.80, p < 0.01) whereas those of patients with 
reactive depression did not.
There were no significant differences in the total plasma CPG 
between any of the groups (Figure 14).
Total plasma cholesterol concentrations were lower in patients 
suffering from endogenous depression than in age-sex-matched controls 
(Table 10, p < 0.05). Patients suffering from reactive depression or 
from other psychiatric disorders did- not differ from matched controls. 
The percentages of free and esterified cholesterol were similar in all 
groups (Table 10).
Changes in the fatty acid composition of the erythrocyte
TABLE 5
The fatty acid composition of the plasma choline phosphoglycerides
of patients suffering from endogenous depression
Results expressed as mean ±S.E. in mg/g total fatty acid methyl esters 
detected.
Figures in parenthesis indicate the number of subjects studied.
Methyl Esters Endogenous Depressives Age-sex-matched Controls
(26) (26)
0 265 ± 4 .5  258 ± 4.3
0 136 ± 3 .6  140 ±3.6
1m9 134 ± 3 .4  132 ±4.6
2W6 199 ± 7 .3  * _ 241 ±7.0
0 4 ± 0 .4  3 ± 0.2
3a)3 + 20:la)9 5 ± 0 . 3  5 ± 0.3
2(d6 4 ± 0 . 3  4 ± 0.3
3a)6 34 ± 1 .4  33 ± 1.3
4u)6 >  112 ± 4 .9  103 ± 3.5
5d)3 20 ± 1 .0 * f 14 ± 0.8
4(d6 3 ± 0 .3  3 ± 0.2
5(d6 3 ± 0.2 2 ± 0.3
16
18
18
18
20
18
20
20
20
20
22
22
22
22
5o)3 16 ±0.8 13 ±0.5
6(d3 64 ± 2.5* 47 ± 1.9
Total LCP 260 ± 7.2““- 222 ± 6.0
p < 0.05
it**
p < 0 . 0 0 1  .
Statistical test employed: paired sample t-test.
TABLE 6
The fatty acid composition of the plasma choline phosphoglycerides
of patients suffering from reactive depression
Results expressed as mean ±S.E. in mg/g total fatty acid methyl esters 
detected. •
Figures in parenthesis indicate the number of subjects studied.
Methyl Esters Reactive Depressives Age-seX-matched Controls
(23) (23)
16:0  262 ± 4 . 7  258 ± 4.0
18:0  138 ± 3 .7  142 ± 3.4
18:lw 9 135 ± 4 .3  132 ± 4.6
18:2w6 236 ± 6 .3  242 ± 6.0
20:0 3 ± 0 .4  2 ± 0.2
18: 3o)3 + 2 0 : lo)9 5 ± 0 . 4  5 ± 0.3
20:2a)6 4 ± 0 .3  4 ±0.2
20:3(*)6 33 ± 1 .3  32 ± 1.0
20:4(d6 106 ± 3 .2  102 ±3.5
2 0 :5w3 14 ± 1 .0  14 ± 0.8
22:4u)6 4 ± 0 .3  3 ± 0.2
22:5a)6 3 ± 0 .2  3 ± 0.2
22:5w3 . 14 ± 0 .7  13 ± 0.6
22:6w3 43 ± 1 .6  45 ± 1.9
Total LCP 224 ± 6.1 218 ± 6.1
There are no significant differences between the two groups• 
Statistical test employed: paired sample t-test.
TABLE 7
The fatty acid composition of the plasma choline phosphoglycerides
of patients suffering from non-depressive psychiatric disorders j
Results expressed as mean ±S.E. in mgfg total fatty acid methyl esters 
detected.
Figures in parenthesis indicate the number of subjects studied.
Non-depressive
Methyl Esters Psychiatric Patients ' 'Age-sex-matched Controls
(11) (11) 1
16
18
18
18
20
18
20
20
20
20
22
22
22
22
0 260 ± 3.2 262 ±4.0
0 143 ± 4.6 137 ± 5.5
lw9 133+3.8 131 ± 4.6
20)6 240 ± 6.4 245 ±6.5
0 - • 4 ± 0.3 3 ± 0.3
3(d3 + 20:lo)9 4 ± 0.3 4 ± 0.3
2o)6 5 + 0.4 4 ±0,2
30)6 33 ± 2,7 * 32 ±1.2
4o)6 99 ± 3.4 101 ± 3.1
5o)3 14 ± 1.4 14 ± 1.1
4o)6 4 ± 0.3 4 ± 0.2
5o)6 3 ± 0.3 3 ± 0.2
5o)3 14 ± 0.8 14 ± 0.7
6o)3 42 ± 2.8 44 ± 2.5
Total LCP 218 ± 6 . 6  219 ± 4.9
There are no significant differences between the two groups. 
Statistical test employed: paired sample t-test.
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Figure 13
Plot of the 22:6to3 content of the-plasma choline phosphoglycerides of 
patients suffering from depressive illness against their Beck Inventory
scores
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phospholipids were in the same direction as those of the plasma but 
were less marked. The erythrocyte EPG of patients with endogenous 
depression (Table 11) contained significantly higher levels of LCP 
(p < 0.05), in particular 22:6w3 (p < 0.05), than those of matched 
controls. Patients with reactive depression and those with other 
psychiatric disorders had similar concentrations to matched controls .
The erythrocyte SPG of patients with endogenous depression (Table 12) 
contained significantly higher levels of 20:5w3 (p < 0.05) than those of 
matched controls. Again, patients with reactive depression and those 
with other psychiatric disorders did not differ from matched controls.
In the erythrocyte CPG (Table 13) the concentration of 18:2o)6 was lower 
in patients with endogenous depression than in matched controls (p <0.05). 
As above, patients with reactive depression and those with other psychiatric 
disorders did not differ from matched controls. The fatty acid composition 
of the erythrocyte sphingomyelin was similar in all groups (Table 14).
Control values for both the plasma and erythrocyte phospholipid 
fatty acids were similar to those reported by other workers (Phillips and 
Dodge, 1967; Dodge and Phillips, 1967; Sanders, 1977). The results of 
the determination of the relative proportions of erythrocyte 
phospholipids revealed that there were no significant differences between 
patients with endogenous depression, patients with reactive depression, 
patients with other psychiatric disorders and controls (Table 15).
Similarly, there was no difference in the cholesterol:phospholipid ratio 
between any of the groups (Table 16).
The results of the haematological investigations are shown in 
Table 17. Patients with endogenous depression (p < 0.05) and those with
A
The fatty acid composition of erythrocyte phospholipids of patients 
with reactive depression and of patients with other psychiatric disorders 
are compared with those of age-sex-matched controls in the Appendix.
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TABLE 10
Plasma cholesterol concentrations of psychiatric patients
Results expressed as mean values ±S,E.
TOTAL FREE ESTERIFIED
(mmol/£) (%) (%)
ENDOGENOUS *
DEPRESSIVES (26) 4.410.2 26.211.5 73.8±1.5
REACTIVE
DEPRESSIVES (23) 5.210.2 25.711.5 74.311.5
OTHER PSYCHIATRIC
PATIENTS (11) 5.610.if'.. 25.812.0 74.212.0
CONTROLS (26) 5.810.2 25.012.4 75.012.4
Figures in parenthesis indicate the number of subjects on whom the 
investigation was carried out.
The control group shown are age-sex~matched to the endogenous depressives
Significant difference from controls (p < 0.05 ).
Statistical test employed: Wilcoxan's test for pair differences•
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reactive depression (p < 0,05) were found to have greater mean 
corpuscular volumes (MCV) than controls. The mean corpuscular haemoglobin 
(MCH) was also greater in patients with reactive depression (p < 0.05) 
but did not reach significance in the endogenous group. No abnormalities 
in the shape of the erythrocytes were detected visually in any of the 
groups when blood films were examined.
W  The Fatty Acid Composition of the Plasma CPG and Erythrocyte 
Phospholipids of Patients Suffering From Postpartum Depression
The plasma CPG of patients suffering from postpartum depression 
(Table 18) contained a higher proportion of LCP (p <0.05), in particular 
22:6w3 (p < 0.05), compared to those of postpartum subjects who were not 
depressed. In addition, the concentration of 18:2u>6 was lower in the 
depressed group (p < 0.05).
The fatty acid and aldehyde composition of the erythrocyte EPG, SPG 
and CPG are shown in Table 19. There were no significant differences 
between the two groups. Similarly, there were no differences in the fatty 
acid composition of the sphingomyelin fraction (Table 20). These 
findings may be due to the small number of patients available for the 
study.
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Discussion
The preliminary-findings of Ellis and Sanders (1977) of a higher 
proportion of LCP, in particular 22:6w3 and 20:5w3, in the plasma CPG 
of patients suffering from endogenous depression have been confirmed 
in a larger series of patients. In addition a reduction in the concentration 
of 18:2w6 was observed in this group. One of the aims of the study was 
to discover whether the measurement of LCP, or more specifically of the 
22:6w3 concentration, would be of value in the diagnosis of endogenous 
depression: the raised 22:6w3 concentration was present in the plasma 
CPG of a subgroup with early symptoms of the illness and of the whole 
group of patients with endogenous depression, 81 percent had a 22:6w3 
concentration of more than 54 mg/g total fatty acid methyl esters detected. 
This compares with 19 percent of matched controls and a similar proportion 
of patients in the other groups. Although the difference is highly 
significant (p < 0 .0 0 1 ) it is insufficient to be of value as the sole 
criterion for diagnosis, but may be of use in conjunction with other 
methods. Nevertheless it must be pointed out that all the depressed 
patients may not have been correctly classified as endogenous or reactive 
using existing clinical criteria. Also it is possible that the high 
22:6w3 concentrations observed in a proportion of apparently healthy 
controls indicates vulnerability to the illness since higher concentrations 
were found in'older subjects in whom monoamine oxidase (MAO) activity 
is higher (Robinson et al., 1972), thereby tending to produce a 
deficiency of serotonin and catecholamines.
High concentrations of LCP, in particular 22:6m3 were also observed 
in patients with postpartum depression. This is of interest since it has 
been suggested that women who suffer from postpartum depression tend to 
have later developments of non-postpartum depression (Thornton, 1977).
The 22:6(o3 concentration of the plasma CPG of patients with 
endogenous depression but not that of patients with reactive depression, 
correlated with the severity of the illness (p < 0.01). The severity 
of depression was similar in both groups.
The lower plasma cholesterol concentrations of the patients 
suffering from endogenous depression was probably due to a reduction in 
appetite, as this occurs more frequently in these patients than in those 
suffering from reactive depression (Dominian, 1976). However it could 
also be the result of an increase in thyroid function (Mathe and 
Chevalier, 1976) reported by some investigators (Kirkegaard et al., 1974; 
Kolakowska, 1977).
The higher MCV and MCH .in the blood of depressed patients suggests 
that their alcohol intake might be greater than that of controls.
Analyses of the fatty acid composition of the erythrocyte 
phospholipids showed changes in the same direction as those of the plasma. 
These differences may be of importance since they could influence 
membrane function, for example the permeability and the activity of 
membrane-bound enzymes (van Deenan, 1971; McElhaney, 1974; Lenaz, 1979). 
Increasing the degree of unsaturation of the phospholipid fatty acid 
weakens the hydrophobic and London-van der Waals cohesive forces acting 
between the hydrocarbon chains of. adjacent lipid molecules, resulting 
in a more loosely packed, more fluid bilayer. On the other hand, increasing 
the chain length of the fatty acid substituents has the reverse effect. 
Double bonds of cis configuration however produce a bending of the 
carbon atom chain thereby shortening the distance between the methyl and 
carboxyl ends of the molecule (Wojtczak, 1976). Hence an increase in LCP 
would tend to increase the fluidity of the membrane. An increase in 
membrane fluidity results in increased passive permeability. The
permeability of artificial membranes to water (Graziani and Livne, 1972; 
Fettiplace, 1978) and of erythrocyte and artificial membranes to 
non-electrolytes such as glycerol and erythritol (van Deenan, 1971) and 
glucose (Demel-et a l . ,  1968; Pilch et a l . ,  1980) has been shown to increase 
with increasing unsaturation of the membrane fatty acids. Furthermore, 
the fatty acid composition of the erythrocyte phospholipids may affect 
the rate of other transport processes. The valinomycin induced Rb+ leak 
from liposomes is determined by the degree of unsaturation of the 
membrane phospholipid fatty acids (van Deenan, 1971). Rb+ is transported 
via the same mechanism as K+ in tissues and in cultured cells (Chen 
et a l . ,  1978). Chan and Fishman (1978) reported that polyunsaturated 
fatty acids induced oedema in slices of rat brain cortex. The 
intracellular sodium concentration was increased while that of potassium 
was reduced. The authors concluded that these fatty acids may have 
affected membrane permeability. Furthermore, Lenaz (1979) suggested that 
the exceptionally high degree of unsaturation of the retinal rod membrane
(with up to 45 percent 22:6w3) may be responsible for the extremely high
+ • * permeability to Na of liposomes derived from rod outer segment lipids,
even when compared with total retinal liposomes.
The interpretation of the results of the present study is complicated 
by the fact that the erythrocyte phospholipids are distributed 
asymmetrically within the bilayer. The CPG and sphingomyelin are mostly 
contained in the outer leaflet whereas the EPG and SPG are localised in 
the inner leaflet (Trams, 1977). This suggests that in normal subjects 
the inner leaflet is more permeable than the outer leaflet. In patients 
suffering from endogenous depression, the total LCP and 22:6w3 
concentrations were increased in the EPG and the concentration of 20:5t»)3 
was increased in the SPG, thereby increasing the fluidity of the inner 
leaflet. The elevation of LCP in the CPG did not reach significance.
The activity of certain membrane-bound enzymes is affected by 
alterations in the phospholipid fatty acid composition. Na -K -ATPase 
activity is localised in the inner leaflet of the membrane (Trams, 1977) 
and is closely related to the active transport system of sodium and 
potassium in human red cells (Bonting and Caravaggio, 1963). There is 
controversy concerning whether this enzyme requires a specific 
phospholipid (SPG) for its activity (Kimelberg and Papahadjopoulos, 1972;
Coleman, 1973) or simply a fluid bilayer (de Pont and Bonting, 1977).
+ + .If the latter is correct, Na -K -ATPase activity would tend to increase
in endogenous depression. Na+-K+-ATPase activity has been shown to 
be increased by prostaglandin (formed from 20:3u)6) and prostaglandin 
(formed from 20:4a)6) (Johnson and Ramwell, 1973), by chronic ethanol 
administration (Israel et al., 1970) and by EFA deficiency (Sun and Sun 
1974; Lin et al., 1979).
The activities of brain MAO and 5 * -mononucleotidase have been found 
to be decreased and that of glucose-6 -phosphatase to be increased in rats 
after a period of lipid deprivation (Bernsohn and Spitz, 1974). On 
refeeding with either 18:2u)6 or 18:3w3, MAO levels returned to normal 
and glucose-6 -phosphatase levels decreased to below normal activity.
Only 18:3u)3 was effective in restoring 51-mononucleotidase activities, 
indicating that 18:3u)3 may have a biochemical function distinct from 
18:2w6 in 5f-mononucleotidase metabolism. Bernsohn and Spitz (1974) 
suggested that the rate of synthesis of the enzyme could be dependent 
on a member of the 0)3 fatty acid series either directly (20:5a)3 or. 22:6(o3) 
or via a prostaglandin mechanism since 2 0 :5 (1)3 is the precursor of 
prostaglandin E and prostaglandin F . Nevertheless it is unlikely
O wCfc
that the increase in LCP in patients with endogenous depression will 
significantly alter the activity of 51-mononucleotidase or MAO since 
both these enzymes are associated with the outer leaflet of membranes
(Trams, 1977; Kandaswami and D'lorio, 1978).
As far as can be ascertained from the literature, the specific
function of 22:6o)3 is unknown. Babcock et al. (1976) studied the 
14incorporation of C-22:6w3 into the lipids of rats. In liver the 
radioactivity appeared most rapidly in the EPG and later in the CPG, 
unlike 18:2oj6 and 20:4w6 which were incorporated most quickly into the 
CPG. This led Babcock et al. to suggest that the function of 22:6w3 
is different from those of other fatty acids. Galli et al. (1977) 
proposed that the w3 series of fatty acids may play a special role in the 
CNS as high concentrations of 22:6w3 are found in brain in comparison 
with other tissues.
Other factors affecting membrane permeability and the activity of 
membrane-bound enzymes are the relative proportions of erythrocyte 
phospholipids and the cholesterol:phospholipid ratio,'but no abnormality 
was found in these parameters in patients suffering from endogenous 
depression. An increase in sphingomyelin (Fettiplace, 1978) or in the 
sphingomyelin:CPG ratio (Cooper et al., 1977) reduces membrane fluidity 
whereas a decrease in the sphingomyelin:CPG ratio (Borochov et al., 1977) 
results in an elevation of membrane fluidity. These changes could be the 
result of differences in the fatty acid composition of the phospholipids 
although the polar groups may play a role in transport processes 
(Robertson and Thompson, 1977). Alterations in the cholesterol: 
phospholipid ratio are concomitant with changes in the shape of the 
erythrocytes (Cooper, 1970; Cooper et al., 1975): no abnormalities were 
observed when blood films were examined. There is some question about 
the distribution of cholesterol within the membrane. Some data indicate 
that the sterol is evenly distributed between the two halves of the 
membrane (Lenard and Rothman, 1976) but Fisher (1976) suggested a partial
enrichment of the outer leaflet (about 2:1). The presence of cholesterol 
in membranes decreases their fluidity (Cooper, 1970; Vanderkooi et al.,
1974; Shinitzky and Inbar, 1976; Cooper, 1978; Lenaz, 1979) and appears 
to limit the penetration of glycerol and erythritol (van Deenan, 1971),
the diffusion of glucose (Demel et alt, 1968) and also to reduce the '
+ tpermeability to Rb (van Deenan, 1971), and Na (Owen and McIntyre, 1978).
Conversely, a decrease in membrance cholesterol results in increased
permeability to glycerol (Bruckdorfer et al,, 1969), acetate, erythritol
and water (Grunze and Deuticke, 1974; Deuticke and Ruska, 1976), Rb
(Chen et al., 1978) and K+ (Le Grimellec and Leblanc, 1978).
Studies of cation transport across red cell membranes have already 
led several investigators to suggest that there is an abnormality of 
cell membrane function in manic-depressive illness (Glen et al., 1968;
Mendels and Frazer, 1973; Mendels and Frazer, 1974, Mendels and Frazer,
1975; Dorus et al., 1979). Lithium ratios (RBC:plasma) were reported to 
be higher in patients suffering from manic-depressive illness than in 
controls (Lyttkens et al., 1973; Ostrow et al., 1978) and depressed 
patients not responding to treatment with lithium carbonate (Mendels and 
Frazer, 1973; Mendels and Frazer, 1974) and to be higher in patients 
with a higher baseline erythrocyte sodium concentration (Mendels and 
Frazer, 1974), Since lithium is not actively removed from red blood cells 
by Na+-K+-ATPase (Maizels, 1968; Duhm and Becker, 1977) Mendels and 
Frazer suggested that the greater lithium ratios in these patients may 
be due to a greater leak of lithium into the cell rather than to reduced 
active transport out of the cell. This is consistent with the observed 
differences in fatty acid composition in the present investigation. However, 
Frazer et al. (1978) found no difference in passive transport of sodium 
across red cell membranes of patients with manic-depressive illness 
compared to that of controls. There is also disagreement as to whether
there is an abnormality of active transport in endogenous depression.
This has been found to be normal by some investigators (Naylor e t  al.,
197 3 ; Frazer e t  a l . , .  1978) but reduced by others (Naylor et a l . ,  1970b; 
Hesketh e t  a l . ,  1977; Choi e t  a l . ,  1977). Thus it is possible that the 
observed differences in the erythrocyte phospholipid; fatty acids may be 
insufficient to produce a significant alteration in membrane function.
Mendels and Frazer (1974; 1975) studied lithium ratios in two groups of 
sheep, one group having red blood cells with high potassium concentrations 
and low sodium concentrations (HKsheep) and the other group having red 
blood cells with low potassium concentrations and high sodium concentrations 
(LKsheep). There is a greater rate of passive diffusion of cations 
across erythrocyte membranes of LK sheep than HK sheep. In addition, 
erythrocyte membranes of LK sheep have lower Na -K -ATPase activity 
than those of HK sheep. Lithium ratios were found to be higher in LK 
sheep, in accordance with their studies of human erythrocytes.
Nelson (1967a) investigated the lipid composition of erythrocytes 
from these two groups of sheep. In agreement with the present investigation 
of human erythrocytes in endogenous depression, no difference was found 
in the relative proportions of phospholipids or in the cholesterol: 
phospholipid ratio. However, in contrast to the present investigation, 
a later study (Nelson, 1969) of the phospholipid fatty acid composition 
did not reveal any differences between the two groups of sheep. This 
anomaly omay be due to the fact that sheep erythrocytes contain very little 
LCP (Nelson, 1969) and therefore reliable detection of abnormalities is 
difficult. There are also species variations in the relative proportions 
of erythrocyte phospholipids (de Gier and van Deenan, 1961; Nelson, 1967b), 
the CPG being absent from sheep erythrocytes.
The erythrocyte has been used by many investigators as a neuronal 
model since there are qualitative similarities in cation transport in 
erythrocytes and nerve cells (Mendels and Frazer, 1974). Quantitatively, 
both passive and active transport of cations occur at greater rates in 
nerve cells (Mendels and Frazer, 1974). This may be related to their 
greater concentrations of LCP. Changes in the proportions of LCP in rat 
erythrocytes have been shown to be reflected in other tissues, including 
liver and brain (Mohrhauer and Holman, 1963a,b,c) although the changes 
were less marked in the brain. Therefore, while it is likely that the 
higher proportions of LCP observed in the plasma CPG and erythrocyte 
phospholipids of patients with endogenous depression and postpartum 
depression are reflected in other tissues, they may not be .of sufficient 
magnitude to affect brain function.
CHAPTER FOUR
THE EFFECT OF TREATMENT ON THE LCP COMPOSITION OF THE PLASMA CHOLINE 
PHOSPHOGLYCERIDES AND ERYTHROCYTE PHOSPHOGLYCERIDES
Introduction
There are several methods available for the treatment of depressive 
illness: EOT, tricyclic antidepressants, MAOI, lithium, L-tryptophan 
and psychotherapy.
ECT, introduced in the 1930*s, is effective in the treatment of 
severe depression of the endogenous type (MRC, 1965; Carney and Sheffield, 
1973; Shaw, 1977; Royal College of Psychiatrists, 1977; Fink, 1977;
Freeman, 1979; Avery and Lubrano, 1979). It has been shown to be 
superior to simulated ECT (Freeman et al., 1978), placebo or MAOI (MRC, 
1965; Royal College of Psychiatrists, 1977; Freeman, 1979) and to be more 
rapidly acting and as good (MRC, 1965; Royal College of Psychiatrists,
1977) or better (Heshe and Roeder, 1976; Avery and Lubrano, 1979; Freeman, 
1979) than tricyclic antidepressants. Bilateral ECT may be more effective 
than unilateral ECT (Abrams and Taylor, 1976) but this is uncertain 
(dfElia and Raotma, 1975). The treatment is however not without risk.
There are an average of 3.0 deaths per year from ECT in England and Wales 
and a number of non-fatal complications associated with the treatment 
(Smith, 1977; Freeman, 1979). Nevertheless, Avery and Winokur (1976) 
found that the mortality rate was lower in patients given ECT than in those 
treated with antidepressant drugs or in untreated depressed patients 
due to the higher rates of suicide in the latter groups. Furthermore, 
the use of muscle paralysing agents, sedation and oxygenation have reduced 
the complications of the treatment (Fink, 1977).
The mechanism of the antidepressant action of ECT is unknown. 
Administration of electroconvulsive shocks to rats has been shown to 
increase the release and turnover of noradrenalin (Kety et a l . ,  1967; 
Thierry et a l . ,  1968; Ebert et a l . ,  1973; Modigh, 1976) and to decrease 
noradrenalin uptake (Hendley and Welch, 1975); to have na effect on 
dopamine and serotonin turnover (Modigh, 1976); to increase the 
concentrations of serotonin (Gandolfi et a l . ,  1978) and GABA (Green 
e t  a l . ,  1978) and decrease the concentration of acetylcholine (Singh
e t  a l . ,  1979) in the brain; to reduce RNA (ribonucleic acid) synthesis
(Wynter, 1979); to increase CSF cyclic AMP (3*5f cyclic adenosine 
monophosphate) concentrations (Clarenbach et a l . ,  1978); and to increase 
the permeability of the blood-brain barrier (Bolwig et a l . ,  1977a). 
Grahame-Smith et a l .  (1978) reported increased behavioural sensitivity 
to agents mimicking the actions of brain monoamines, which might be 
accounted for by increased receptor responses. Other workers found that 
electroconvulsive shock reduced the sensitivity of 8 -adrenergic receptors 
(Bergstrom and Kellar, 1979; Pandey et a l , ,  1979) but had no effect on 
the sensitivity of o-adrenergic or serotonergic receptors (Bergstrom and 
Kellar, 1979). It has also been suggested that electroconvulsive shock 
may produce an increase in the number of synaptic vesicles (Jorgenssen and 
Bolwig, 1979). In man, ECT has been reported to have no effect on the 
CSF concentrations of HVA, 5HIAA or tryptophan (Abrams et a l . ,  1976); 
to increase prolactin secretin (Ohman et a l . ,  1976; OfDea et a l . ,  1978; 
Klimes et a l . ,  1978); stimulate ACTH and cortisol production (Ylikorala 
e t  a l . ,  1976; Delitala et a l . ,  1977); to have no effect on serum TSH
(Ryan et a l . ,  1970; Ylikorala et a l . ,  1976; Delitala et a l . ,  1977); to
decrease CSF calcium concentrations (Carman et a l . ,  1977); and to increase 
the permeability of the blood-brain barrier (Bolwig et a l . ,  1977b). In 
addition, plasma and urinary levels of cyclic AMP may be increased by
ECT (Hamadah e t  a l . ,  1972; Holmes, 1975), but Ylikorala e t  a l .  (1976) 
failed to find any consistent change in plasma cyclic AMP concentrations 
after ECT. Measurements of the concentrations of FSH, LH and growth 
hormone in serum before and after ECT have also yielded conflicting 
r e s u lts  (Ryan e t  a l . ,  1970; Ylikorala e t  a l . ,  1976; Delitala e t  a l . ,  1977).
The MAOI and tricyclic antidepressants were introduced in the 1950's. 
The former have been relegated to a lesser role in the treatment of 
depressive illness as they are less effective and more toxic than the 
tricyclics (Mielke, 1976).
The MAOI prevent amine catabolism by inhibiting monoamine oxidase 
and the tricyclics prevent amine inactivation by inhibiting amine 
reuptake into presynaptic neurones (Carlsson, 1976; Carlsson and 
Lindquist, 1978). The therapeutic effect of both these groups of drugs 
is thought to be due to the resultant increase in noradrenalin and/or 
serotonin availability at functionally important receptor sites (Carlsson, 
1976; Carlsson and Lindquist, 1978; de Montigny and Aghajanian, 1978; 
Sangdee and Franz, 1979), Tricyclics also inhibit acetylcholine synthesis 
(Halaris and Karbowski, 1979). Some may increase prolactin secretion 
(Cole e t  a l . ,  1976; Francis e t  a l . ,  1976; Slater e t  a l . ,  1977; Mendelwicz 
and Youdim, 1977) but this has been contradicted (Meltzer e t  a l . ,  1977); 
some have been found to increase serum TSH concentrations (Linnoila e t  a l . ,
1977); and to reduce plasma cortisol concentrations (McClure, 1966b).
Lithium was first introduced in 1949 for the control of mania and is 
now used to control both unipolar and bipolar depressive illness. It is an 
effective prophylactic agent (Coppen e t  a l . ,  1971b; Lancet, 1972; Coppen 
e t  a l . ,  1973b; Schou, 1979), reducing the mean percentage of patients 
becoming ill within one year of commencing treatment from approximately 
70 percent to 20 percent, compared with a reduction to 35 percent when 
tricyclics were used (Schou, 1979).
There have been a large number of investigations of the metabolic 
effects of lithium. Briefly, these include effects on noradrenalin 
metabolism (Colburn et al., 1967; Stern et al., 1969; Schildkraut et al.,
1969b; Gershon, 1972), dopamine metabolism (Corrodi et al., 1969;
Friedman and Gershon, 1973), serotonin metabolism (Schildkraut et al.,
1969a; Sheard and Aghajanian, 1970; Perez-cruet et al., 1971; Collard,
1978), acetylcholine metabolism (Yizi, 1975; Jope, 1979), serum 
electrolyte concentrations (Christiansen et al., 1978; Srinivasan et al.,
1978; Hariharasubramanian et al., 1978), membrane transport (Glenn and 
Reading, 1973; Lingsch and Martin, 1976; Hesketh, 1976; Martin, 1978;
Dick et al, 1978; Glen, 1978; Beaug^, 1978; Coppen et al., 1980), hormone- 
stimulated prostaglandin synthesis (Horrobin et al., 1978), carbohydrate 
metabolism (Lazarus, 1978; Plenge, 1978; Vendsborg, 1978), thyroid
;
function (Bagchi et al., 1978), serum LH (Sheard et al., 1977) and cyclic 
AMP formation (Krulick, 1977; Geisler et al., 1978; Geisler and Klysner,
1978; Zatz, 1979).
Studies of the effect of tryptophan on the recovery of depressed 
patients have yielded conflicting results (Coppen et al., 1967b; Broadhurst, 
1970; Coppen and Noguera, 1970; Carroll et al., 1970; Coppen et al.,
1972c; Dunner and Goodwin, 1972; Herrington et al., 1974, 1976) but a number of 
workers have reported that tryptophan potentiates the effect of MAOI 
(Coppen et al., 1963; Pare, 1963; Coppen et al., 1967b; Glassman and 
Platman, 1969) and tricyclics (Walinder et al., 1976).. The efficacy of 
ECT was however unaffected by the addition of tryptophan (d'Elia et al.,
1977; Kirkegaard et al., 1978b). Other monoamine precursors have not been 
found to affect the recovery of depressed patients (Carroll, 1971; Nahunek 
et al., 1972) with the possible exception of phenylalanine (Fischer 
et al., 1975).
Psychotherapy is of value in the treatment of reactive depression 
(Luborsky et al., 1975) but is frequently used as an adjunct to 
pharmacological treatment.
The review of the literature has shown that ECT and the pharmacological 
agents used in the treatment of depressive illness alter the metabolism 
of biogenic amines, electrolytes and hormones and may also affect membrane 
function. For example, tricyclic antidepressants inhibit amine reuptake 
into presynaptic neurones. It was suggested in Chapter three that the 
high LCP concentrations in patients suffering from endogenous depression 
may increase membrane permeability. It is possible that a decrease in 
these values during treatment would have the reverse effect and perhaps 
explain the mode of action of the tricyclics. Therefore the LCP composition 
of the plasma CPG and erythrocyte phosphoglycerides were determined 
during treatment of depressive illness.
Patients and Methods
Twelve patients suffering from endogenous depression and six patients 
suffering from reactive depression were studied. The mean age of patients
with endogenous depression was 49 years, ranging from 21 to 72 years. The
mean age of patients with reactive depression was 34 years, ranging from 
18 to 48 years. All the patients in the endogenous group suffered from 
unipolar illness. Eight of the, patients with endogenous depression 
(67 percent) and four of those with reactive depression (67 percent) were 
drug-free for at least two weeks before the beginning of the study. The
remainder were receiving a hypnotic.
Blood samples were taken before treatment commenced and at the 
following times thereafter: one week, two weeks, four weeks and at twelve 
weeks. The severity of depression was assessed by the Beck Inventory
before treatment and at four weeks and twelve weeks after the beginning 
of treatment.
Of the patients suffering from endogenous depression, two were 
given ECT and ten were treated with tricyclic antidepressants. Of the 
patients with reactive depression, two received tricyclic antidepressants, 
one received a tranquilliser and three received psychotherapy.
In addition, the fatty acid composition of the plasma choline 
phosphoglycerides of fifteen patients receiving prophylactic lithium 
treatment was determined. Ten of the patients were classified as 
unipolar and five as bipolar, but none were depressed at the time of 
study. The mean age was 53 years, ranging from 35 to 64 years. Thirteen 
of the patients had received lithium for several years and two had 
received lithium for one year. Only one patient received other drugs 
(codeine and aspirin) in the two weeks prior to the study.
Results
The fatty acid composition of the plasma CPG of patients suffering 
from endogenous depression is shown in Table 21. Compared to the values 
before treatment, the total LCP concentration was significantly lower 
at two weeks (p < 0 .0 2 ), four weeks (p < 0 .0 0 1 ) and twelve weeks (p < 0 .0 0 1 ) 
after treatment commenced. Regarding the individual fatty acids, the 
concentration of 22:6w3 was significantly lower at two weeks (p < 0.05), 
four weeks (p < 0 .0 0 1 ) and twelve weeks (p < 0 .0 0 1 ); the concentration of
20:4w6 was significantly lower at four weeks (p < 0.01) and twelve weeks
(p <0.01); the concentration of 20:5w3 was significantly lower at four 
weeks (p < 0 .0 1 ) and twelve weeks (p < 0 .0 1 ); and the concentration of
22:5w3 was significantly lower at four weeks (p < 0.05) after treatment
commenced. Compared to the values at two weeks after the beginning of
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treatment, the total LCP concentration was lower at four weeks (p < 0.01) 
and twelve weeks (p < 0.01); the concentration of 22:6w3 was lower at 
four weeks (p < 0 .0 0 1 ) and twelve weeks (p < 0 .0 2 ); and the concentration 
of 20:4w6 was lower at four weeks (p < 0.05) and twelve weeks (p < 0.05).
In addition, the concentration of 18:2u)6 was higher at four weeks (p < 0 .0 2 ) 
and twelve weeks (p < 0 .0 2 ) after treatment commenced compared with the 
concentration before treatment. The 22:6w3 concentration at twelve weeks 
was higher than at four weeks, but this was not significant.
The fatty acid composition of the plasma CPG of patients suffering 
from reactive depression is shown in Table 22. There was no significant 
alteration during treatment. LCP concentrations in both endogenous 
and reactive patients before treatment were similar to those reported in 
chapter three.
In the erythrocyte EPG of patients with endogenous depression 
(Table 23), the concentration of 22:6 w3 was lower at four weeks (p < 0.05) 
and twelve weeks (p <0.05) and the total LCP concentration was lower at 
twelve weeks (p < 0.05) after treatment commenced compared to the values 
before treatment. In contrast, there was no significant alteration in the 
fatty acid composition of the erythrocyte EPG of patients being treated 
for reactive depression (Table 24).
In the erythrocyte SPG of patients with endogenous depression (Table 
25), the total LCP concentration was lower at twelve weeks after the 
beginning of treatment (p < 0.05) compared to the concentration before 
treatment. As above, there was no alteration in the fatty acid composition 
of the erythrocyte SPG of patients being treated for reactive depression 
(Table 26). ’
The erythrocyte CPG of patients with endogenous depression (Table
27) showed a significant decrease in total LCP (p < 0.05) and increase
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in 18:2(o6 concentrations twelve weeks after the beginning of treatment. 
Again, there was no alteration in the fatty acid composition of the 
erythrocyte CPG of patients being treated for reactive depression (Table
28).
Of the patients suffering from endogenous depression, the mean 
score on the Beck Inventory before treatment was 26, ranging from 18 
to 38. After four weeks treatment the mean score was 12, ranging from 
3 to 18; a decrease of 54 percent. The mean score at twelve weeks after 
the beginning of treatment was 8 , ranging from 0 to 14; a decrease of 
69 percent compared to the pretreatment scores. Of the patients 
suffering from reactive depression, the mean score on the Beck Inventory 
before treatment was 24, ranging from 15 to 27. After four weeks 
treatment the mean score was 15, ranging from 0 to 20; a decrease of 
37 percent. The mean score at twelve weeks after the beginning of 
treatment was 7, ranging from 0 to 15; a decrease of 71 percent compared 
to the pretreatment scores.
The 22:6w3 content of the plasma CPG of patients with endogenous 
depression correlated with the Beck Inventory scores before treatment 
(see chapter three). However there was no correlation at 4 weeks or 
at 1 2  weeks after treatment commenced.
The LCP composition of the plasma CPG of patients receiving 
prophylactic lithium treatment is shown in Table 29. Concentrations were 
not significantly different from those of age-sex-matched controls, 
although the concentration of 22:6w3 tended to be higher.
Discussion
Analysis of the Beck Inventory scores revealed that there was a 
substantial clinical improvement in both endogenous and reactive patients
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during treatment. This was accompanied by a decrease in the 
concentrations of LCP and increase in the concentration of 18:2u6 in 
the plasma CPG and erythrocyte phosphoglycerides of patients being 
treated for endogenous depression, but not in those of patients being 
treated for reactive depression. The lack of correlation of the 22:.6u3 
concentrations in the endogenous group with the Beck Inventory scores 
at *+ weeks and at 1 2  weeks after the beginning of treatment may have 
been due to the low depression ratings. In the plasma CPG of the 
endogenous group, the concentrations of total LCP and 22:6w3 were unchanged 
one week after treatment commenced but had decreased slightly by two 
weeks. This is in agreement with the fact that antidepressant drugs 
(with which most of the patients were treated) require two to three 
weeks administration before a clinical response is observed (Mitchell,
1975; Segal et al., 1976).
The concentrations of total LCP, 2 2 :6 w3 , 20:5^3 and 18:2&6 had reached 
normal values by four weeks. There were also decreases in the 
concentrations of 20;*iw6 and 22:5w3 even though the concentrations of 
these fatty acids were not significantly elevated before treatment.
These changes were reflected in the fatty acid composition of the 
erythrocyte phosphoglycerides but were less marked, only reaching 
significance at twelve weeks after the beginning of treatment.
The concentration of 22:6w3 in the plasma CPG of the endogenous
/
group increased slightly between four weeks and twelve weeks after 
treatment commenced and patients who had received prophylactic lithium 
treatment for at least a year tended to have higher 22:6co3 concentrations 
than matched controls. Although neither of these differences were 
statistically significant, they suggest that the effect of treatment on 
phosphlipid fatty acid composition may be only temporary.
The decrease in phospholipid LCP concentrations would tend to 
reduce membrane permeability and may therefore explain the inhibitory 
effect of tricyclic antidepressants on amine reuptake.
Bazan and his co-workers (Bazan, 1970; Bazan and Rakowski, 1970;
Bazan, 1971) showed that free fatty acid levels, especially 20:4w6, 
increased in the brains of rats after electroconvulsive shock. They 
suggested that this was due to the activation of phospholipase ^  (Bazan, 
1970; Bazan and Rakowski, 1970) possibly by noradrenalin (Bazan et al., 
1971). This would tend to increase prostaglandin synthesis (Horton,
1975; Flower and Blackwell, 1976). In fact, prostaglandins have been 
found in increased amounts in human CSF following epileptic seizures 
(Wolfe et al., 1977). Electroshock has also been reported to reduce 
the incorporation of labelled free 20;4w6 into lipids (Rodriguez de Turco 
et al., 1977), although the effect was only temporary. Therefore it is 
possible that the observed decrease in the concentrations of prostaglandin 
precursors (20;4w6 and 20:5w3) was due either to increased release of these 
fatty acids from phospholipids or to their reduced incorporation into 
phospholipids. The former hypothesis is the most likely since biogenic 
amines, which are increased at functionally important receptor sites 
after electroconvulsive shock (Modigh, 1976) or antidepressant drug 
treatment (Carlsson, 1976), increase the synthesis of prostaglandin 
^2a ^°-^e et 1977). Gross et al. (1977) found a slight increase
in the synthesis of prostaglandins of the F series with chronic lithium 
treatment, but L-tryptophan had the reverse effect. Prostaglandin F2 o 
may enhance the release of neurotransmitters (Horton, 1973). On the 
other hand, prostaglandins of the E series exert negative feedback on the 
presynaptic neurone to prevent transmitter release (Horton, 1973; Craig, 
1975; Craig, 1976). Prostaglandins of the E series also promote transmitter 
reuptake into the presynaptic neurone (Hedqvist, 1974; Hedqvist, 1976),
an action which is antagonised by tricyclic antidepressants (Carlsson, 
1976; Manku and Horrobin, 1976),
In conclusion, from published work it seems likely that the 
observed decrease in phospholipid LCP concentrations .was due to increased 
release of these fatty acids from phospholipids, with a subsequent 
increase in prostaglandin F2 a synthesis. However, the present study 
suggests that the effect may be only temporary.
CHAPTER FIVE
THE FATTY ACID COMPOSITION OF THE PLASMA CHOLINE PHOSPHOGLYCERIDBS 
AND ERYTHROCYTE PHOSPHOLIPIDS OF ORAL CONTRACEPTIVE USERS
Introduction
Some studies have shown that depression is a side-effect of oral 
contraceptive use (Nilsson and Almgren, 1968; Lewis and Hoghughi, 1969; 
Herzberg and Coppen, 1970; Herzberg et al., 1970; Parry and Rush, 1979; 
Warnes and Fitzpatrick, 1979) and that it is a common cause of women 
stopping the pill (Dennis and Jeffrey, 1968; Parviz and Behrmann, 1976), 
but others found no evidence for this (Zell and Crisp, 1964; Goldzieher 
et al., 1971; Kutner and Brown, 1972a; b; Fleming and Seager, 1978). 
Goldzieher et al. (1971) found no increase in the overall incidence of 
depression among three hundred and ninety-eight women in a cross-over 
design involving a placebo and one of four oral contraceptive agents.
In fact it has been suggested that a proportion of women using oral 
contraceptive agents experience an increased sense of well-being (Moos, 
1968) and an improvement in sexual adaptation (Zell and Crisp, 1964;
Nilsson et alt> 1967). Moos (1968) found that 10 percent of the women 
studied reported an increase in well-being while another 1 0  percent 
reported a decrease. Herzberg and Coppen (1970) demonstrated that 
dysmenorrhoea and premenstrual depression and irritability were relieved 
by oral contraceptive agents. The incidence of depression induced by oral 
contraceptive agents in this study was found to be between 5 percent 
and 1 0  percent.
The symptoms of depression induced by oral contraceptive agents 
differ from those of endogenous and reactive depression: pessimism, 
dissatisfaction, crying and tension being predominant, whereas sleep
disturbance and appetite disorders are rare (Herzberg et al., 1970).
Grant and Pryse-Davies (1968) reported that the incidence of 
depression was lowest among women using sequential formulations (fourteen 
to sixteen days of oestrogen alone, followed by seven to five days of 
oestrogen and progestogen combined). In a more recent study (Allen, 
197H), the incidence of depression was found to be lowest among women 
using a very low dose combined pill (30pg of oestrogen plus 150pg of 
progestogen).
The occurrence of depression has usually been blamed on the 
progestogen component of the pill (Grant and Pryse-Davies, 1968; Lewis 
and Hoghughi, 1969) but the oestrogen component has also been held 
responsible (Cullberg, 1972a). However, Waxman (1968) claimed to have 
relieved depression by the administration of progesterone and Leeton 
(1973) stated that the oestrogen-progestogen balance was unimportant. 
Other workers have suggested that individual susceptibility may be more 
important than the composition of the pill in the development of 
depression (Herzberg and Coppen, 1970; Herzberg et al,9 1970; Grounds 
et al.9 1970; Fortin et al., 1972; Cullberg, 1972b). Women who developed 
depression as a side effect of oral contraceptive use were found to have 
higher neuroticism scores (using the MMPI ) or to have more premorbid 
psychiatric symptoms (Herzberg and Coppen, 1970; Herzberg et al.9 1970) 
or to have negative expectations about oral contraceptive agents (Grounds 
et al., 1970; Fortin et al., 1972; Cullberg, 1972b). Women with a 
history of psychiatric disorder, particularly depression (Nilsson et al., 
1967; Lewis and Hoghughi, 1969) and especially those with a history of 
psychiatric disturbances during pregnancy (Nilsson and Almgren, 1968) 
or in the postpartum period (Marcotte et al., 1970) have been found to 
be at risk of developing depression during oral contraceptive use.
iV
Minnesota Multiphasic Personality Inventory.
Rose (1966a, b) discovered that women who were using an oestrogen 
and progestogen combined oral contraceptive agent had a greatly increased 
urinary xanthurenic acid excretion after a loading dose of tryptophan. 
Subsequent studies confirmed this observation and showed that the 
urinary excretion of kynurenine, 3-hydroxy-kynurenine and to a lesser 
extent 3-hydroxyanthranilic acid (see Figure 15) were also raised in 
combined pill users after a loading dose of tryptophan (Price et al.,
1967; Rose, 1972; Ahmed et al., 1975; Horwitt et al., 1975; Haspels 
et al., 1975; Green, 1978; Donald and Bosse, 1979), This was thought 
to be due to the induction of tryptophan pyrrolase, the rate-limiting 
enzyme in the tryptophan-nicotinic acid pathway, by oestrogen (Rose,
1966b; Rose and Braidman, 1970). The enhanced metabolism of tryptophan 
via this pathway means that less will be available for serotonin synthesis. 
However, Green (1978) reported that although oral contraceptive users 
excreted greater amounts of tryptophan metabolites of the kynurenine 
pathway, the excretion of 5HIAA was normal. He also suggested that since 
the plasma half-life and plasma clearance of tryptophan and the area 
under the plasma tryptophan curve were similar in oral contraceptive 
users and non-users, tryptophan pyrrolase activity may be normal in 
women using oral contraceptives. Total (Coppen et al., 1973c; Moller,
1979) and free (Coppen et al.9 1973c) plasma tryptophan concentrations 
were found to be normal in oral contraceptive, users but plasma tyrosine 
concentrations were low (Potera and Rose, 1978; Moller, 1979) indicating 
reduced formation of catecholamines.
It can be seen from Figure 15 that several of the enzymic reactions 
in the tryptophan-nicotinic acid pathway require pyridoxal phosphate 
(a form of vitamin B^) as coenzyme. The enhanced metabolism of tryptophan 
via this pathv/ay therefore increases the requirement for vitamin B^.
A further increase in the requirement arises from the fact that oestrogen
Figure 15
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conjugates compete for pyridoxal phosphate binding sites on the 
apoenzyme (Wynn, 1975). The level of plasma pyridoxal phosphate may 
be reduced in oral contraceptive users (Lumeng et al., 1974; Prasad 
et al.9 1975). In addition, evidence of tissue depletion of vitamin 
Bg has been shown by reduced activity and saturation with coenzyme 
in vitro of pyridoxal phosphate dependent red cell aminotransferases 
(Rose et al., 1972; Driskell et al., 1976; Bamji, 1978; Bosse and 
Donald, 1979).
A deficiency of vitamin Bg in combined pill users could account for 
the occurrence of depression and of impaired glucose tolerance in these 
women (Wynn, 1975). Adams et al. (1973; 1974) studied depressed women 
whose symptoms were judged to be due to the effects of oral contraceptive 
agents and found biochemical evidence of vitamin Bg deficiency in 
50 percent of these. In a cross-over double-blind trial, the 
administration of pyridoxine hydrochloride (40mg daily) produced a 
significant improvement in the Bg deficient women. No improvement 
occurred in the non-deficient women, or with placebo in either group.
The abnormal tryptophan metabolism (Rose, 1966; Price et al,9 1967;
Adams et al., 1973; Haspels et al., 1975; Donald and Bosse, 1979) and 
impaired glucose tolerance (Wynn, 1975) have also been demonstrated to 
improve with vitamin Bg supplementation.
It is possible that the incidence of depression in oral contraceptive 
users is also related to folic acid deficiency since this would reduce 
serotonin synthesis (Botez et al., 1979). There are many reports in 
the literature of low serum and red cell folic acid concentrations and 
raised urinary FIGLU (foriminoglutamic acid) excretion after a 
histidine load in women using oral contraceptive, agents (Shojania 
et al., 1968; Shojania et al., 1971; Shojania et al., 1975; Smith et al.,
1975; Ahmed et al,, 1975; Lancet, 1975; Wynn, 1975; Lindenbaum et al,9 
1975; Prasad et al.9 1975; Journal of the American Medical Association, 
1976; Areekul et al*9 1977; Bamji, 1978; Massey and Davison, 1979).
Da Costa and Rothenberg (1974) identified a macromolecular factor in 
leucocyte lysates of oral contraceptive users which binds unreduced 
folates and dihydrofolate.
Oral contraceptive agents have also been demonstrated to adversely 
affect the body^ economy of other vitamins: riboflavin (Lancet, 1975;
Wynn, 1975; Ahmed et al., 1975; Ahmed and Bamji, 1976; Bamji, 1978;
Newman et al., 1978), vitamin B ^  (Lancet, 1975; Wynn, 1975; Journal of 
the American Medical Association, 1976), vitamin C (Lancet, 1975;
Wynn, 1975) and vitamin A (Lancet, 1975; Wynn, 1975; Ahmed et al., 1975; 
Bamji, 1978; Bamji and Ahmed, 1978; Vahlqvist et al., 1979).
Oral contraceptive.agents have many other more serious adverse 
effects. These include the frequently publicised effects on the 
cardiovascular system: deep vein thrombosis, pulmonary embolism,
hypertension, stroke and acute myocardial infarction (Lancet, 1977;
Royal College of General Practitioners, 1977a,b; Vessey et al»9 1977; 
British Medical Journal, 1977; Jaffe, 1977; Kaplan, 1978; Vessey, 1978; 
Lancet, 1979; McEwen, 1979), which are thought to be due to the oestrogen 
component of the pill (Poller, 1978; McQueen, 1978; Shapiro et al,,
1979).
There is evidence that the fatty acid composition of the plasma 
CPG and erythrocyte phospholipids may be affected by a deficiency of 
vitamin Bg (Dussault and Lepage, 1975; Delorme and Lupien, 1976a) or 
vitamin B ^  (Peifer and Lewis, 1979) and may also reflect risk of 
cardiovascular disease (Dyerberg et al., 1978). Therefore these were 
determined in women using oestrogen and progestogen combined oral 
contraceptive agents and~in women using progestogen-only oral contraceptive
agents.
Subjects
Twenty women using oestrogen and progestogen combined and six 
women using progestogen-only oral contraceptive agents were studied.
The mean age of the combined pill users was 26 years, ranging from 19 
to 37 years. The mean age of the progestogen-only pill users was also 
26 years, ranging from 18 to 40 years. The combined pill group had 
been using oral contraceptives for an average of 27 months, ranging 
from 6 to 65 months. The progestogen-only group had been using them 
for an average of 12 months, ranging from 3 to 24 months. Of the 
combined pill users, fifteen were using a pill containing 30yg of 
oestrogen, 2 were using a pill containing 35yg of oestrogen and 3 were 
using a pill containing 50yg of oestrogen. None of the subjects were 
depressed at the time of the study, probably due to the low steroid 
doses used. Controls were women who had never used oral contraceptives 
or who had not used oral contraceptives for at least six months prior 
to the study.
i
Results
The fatty acid composition of the plasma CPG is shown in table 30. 
The combined pill group had higher concentrations of 16:0 (p < 0.05), 
and 18:2w6 (p < 0.05) and lower concentrations of 18:0 (p < 0,05),
20:4m6 (p < 0.05), 20:5w3 (p < 0.05), 22:5u)3 (p < 0.01) and total LCP 
(p < 0.05) than matched controls. The progestogen-only group did not 
differ from matched controls in respect of any of the fatty acids.
Similar differences were observed in the erythrocyte phospholipids, 
significant differences occurring only in the combined pill group. Their
EPG (table 31) contained a higher concentration of 18;2m6 (p < 0.05) 
and lower concentrations of 20:4w6 (p < 0.05), 20:5w3 (p <0.05),
22:5^3 (p < 0.01) and total LCP (p < 0.05) than matched controls.
The erythrocyte SPG (table 32) of combined pill users contained
a higher concentration of 18:2u)6 (p < 0,05) and lower concentrations of
22:5w3 (p < 0.01) and total LCP (p < 0.05) than matched controls.
The erythrocyte CPG (table 33) of combined pill users contained a
higher concentration of 18:2w6 (p < 0,05) and lower concentrations of
18:0 (p < 0.05) and 22:5^3 (p < 0.01) than matched controls.
The fatty acid composition of the erythrocyte sphingomyelin was 
similar in all three groups (table 34).
Discussion
Analyses of the fatty acid composition of the plasma CPG and
erythrocyte phospholipids showed that women using oestrogen and progestogen
combined oral contraceptive agents had higher concentrations of 18:2tu6
and lower concentrations of LCP than matched controls. Women using
progestogen-only oral contraceptive agents had similar concentrations
to matched controls, indicating that the oestrogen component was
responsible for the differences. Vitamin deficiency in rats has been
reported to increase the concentration of 18:2oj6 and decrease the
concentration of 20:4to6 in tissue lipids (Mueller and Iacono, 1963;
Dussault and Lepage, 1975; Delorme and Lupien, 1976a). The reverse
occurred with vitamin supplementation (Scheier and Williams, 1964;
Delorme and Lupien, 1976b). Therefore it is likely that the higher
18:2w6 and lower 20:4w6 and total LCP concentrations in combined pill
users were due to a reduced vitamin B_ status. The lower concentrationb
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of 22:5w3 in these women may also be a result of vitamin Bg deficiency, 
since Goswami and Coniglio (1966) found that vitamin Bg supplementation 
produced an increase in the concentration of 22:5w3 in rat testicular 
lipids.
Deficiency of vitamin Bg does not reduce the synthesis of 2 0 :4 0 ) 6  
from 18:2o)6 (Dussault and Lepage, 1975). Dussault and Lepage (1975) 
found that the incorporation of 20:4w6 into liver lipids was reduced in 
vitamin Bg deficient rats, but in a later study (Dussault and Lepage, 1979) 
they showed that the incorporation of 20:4u)6 into liver lipids was 
normal but that the incorporation of 16:0 and 18:2o)6 was increased.
Delorme and Lupien (1976b) postulated that in vitamin Bg deficiency 
there may be an alteration in the relative importance of the two pathways 
by which the CPG are synthesised: a relative decrease in the methylation 
of EPG (which produces CPG with a high LCP and low 18:2^6 content) and 
increase in the CDP-choline (cytidine disphosphocholine) pathway (which 
produces CPG with a low LCP and high 18:2w6 content). If this is correct, 
it would explain the findings of the present study.
Deficiency of thiamin (Williams et al., 1967) or of vitamin B ^
(Peifer and Lewis, 1979) affects fatty acid metabolism in the same way as 
vitamin Bg deficiency. Thiamin deficiency does not occur in women using 
oestrogen and progestogen combined oral contraceptive agents (Ahmed et al,t
1975), but vitamin B^ 2 deficiency has been reported (Lancet, 1975; Wynn,
1975; Journal of the American Medical Association, 1976). The latter may 
therefore be partly responsible for the observed differences in
phospholipid fatty acid composition in these women.
It has been suggested that the high concentration of 20:5w3 in the 
lipids of Eskimos protects them against thrombosis (Dyerberg et al., 1975; 
Dyerberg et al., 1978) as this fatty acid does not induce platelet aggregation
in human platelet-rich plasma. This was thought to be due to the 
formation of thromboxane which does not have platelet aggregating 
properties and also to the synthesis of an anti-aggregating agent, a 
prostacyclin of the "3" series (Dyerberg et al,y 1978). Thus it is 
possible that the low concentration of 20;5w3 in the plasma CPG and 
erythrocyte phosphoglycerides of women using oestrogen and progestogen 
combined oral contraceptive agents may relate to their increased risk 
of thrombosis. According to Dyerberg et al. (1978) the ratio of 
20:4u>6 : 20:5io3 is important, higher ratios indicating higher risk. In 
the plasma CPG of combined pill users the ratio was 10, compared with 7 
in the controls. Even higher values would be expected in women taking 
higher doses of these steroids.
The low concentrations of LCP in the erythrocyte phosphoglycerides 
of combined pill users may reduce the permeability of the membrane and 
affect the activity of certain membrane-bound enzymes (van Deenan, 1971; 
McElhaney, 1974). ATPase activities have been reported to be normal in 
combined pill users (Kaplay and Ramanadham, 1978) but Kamyab et al, (1978) 
found a lower urinary excretion of potassium. The}' suggested that this 
may be due to a retention of potassium within cells. Kaplay and 
Rarnanadham (1978) showed that erythrocyte potassium concentrations tended 
to be higher in combined pill users but were not significantly different 
from those of controls.
In conclusion, it appears that the differences in phospholipid
fatty acid composition observed in women using oestrogen and progestogen
combined oral contraceptive agents were a result of their reduced
vitamin B_ and B,0 status. Unfortunately none of these women were depressed 
6 12
at the time of the study. This was probably due to the low steroid 
doses used (Allen, 1974): women using oral contraceptive agents containing
more than 50yg of oestrogen were not available for study. The low 
concentrations of LCP and high concentration of 18:2w6 found in combined 
pill users were the opposite of those observed in patients suffering from 
endogenous depression (chapter three).
CHAPTER SIX
FACTORS AFFECTING PHOSPHOLIPID TjCP COMPOSITION 
Introduction
The aetiology of the high LCP concentrations in the plasma 
CPG, and to a lesser extent in the erythrocyte phospholipids, of 
patients suffering from endogenous depression is not clear. The 
abnormality could be due to increased dietary intake or to increased 
production of these fatty acids. Alternatively, the high LCP 
concentrations could be the result of a greater rate of incorporation 
of these fatty acids into lipids or a low phospholipase A? activity.
LCP are found in animal products (Crawford and Sinclair, 1972), 
the main sources of 22;6m3 being brain, liver, fish, ::.chicken, turkey 
and egg (Paul and Southgate, 1978).
A6 desaturase is the rate limiting enzyme in the synthesis of
LCP (Castuma et al,9 1972; Brenner, 1974; Brenner, 1977) and requires
2t
a number of cofactors (CoA, ATP, Mg' and NADH) for optimum activity 
(Cook, 1978). There are also several other factors - dietary and 
hormonal (de Gomez Dumm et al,t 1970; Peluffo et al., 1971; Faas et al., 
1972; Brenner, 1974; Peluffo et al., 1976; de Gomez Dumm et al., 1976; 
de Gomez Dumm et al., 1977a,b; Faas et al., 1977; Brenner, 1977) - which 
affect the activity of this enzyme (see Table 35). There is controversy 
concerning the effect of thyroxine on A6 desaturase: in vitro studies 
have shown an increase in A6 desaturase activity (Faas et al., 1972;
Faas et al., 1977) but in vivo studies have shown that thyroxine depresses 
A6 desaturase activity (de Gomez Dumm et al., 1977b). The latter workers 
measured the desaturation reaction through the conversion of labelled 
18:2w6 to 18:3to6 in rat microsomes whereas in the studies of Faas et al.,
TABLE 35
Factors influencing A6 desaturase activity
1. Diet
2. Hormones
Induction of Enzyme Depression of Enzyme
EFA deficiency Fasting
Protein Carbohydrates
Insulin Glucagon
Adrenalin
Thyroxine
ATP Cyclic AMP
4. Environmental 
temperature Reduction Increase
(1972; 1977) only indirect conclusions were obtained. Thus it seems 
more likely that thyroxine depresses A6 desaturase activity.
The results of chapter five suggest that oestrogen may also affect 
phospholipid LCP composition. Furthermore, many of the patients studied 
were receiving a hypnotic and/or tranquilliser so that the effects of 
these require evaluation.
The effects of drugs, diet and hormones on phospholipid LCP 
composition were therefore investigated. It was not possible to measure 
the rate of incorporation of LCP into lipids or phospholipase A2 activity 
due to ethical considerations in humans and the difficulty of producing 
the syndrome of endogenous depression in experimental animals.
Methods and Results
(a) Effect of Drugs
The effects of nitrazepam (Mogadon), flurezepam (Dalmane), diazepam . 
(Valium) and chlormethiazole edisylate (Heminevrin) on the fatty acid 
composition of the plasma CPG were investigated experimentally using 
adult female Wistar albino rats. Each drug was mixed with distilled 
water and administered with the aid of an oral dosing needle to a group 
of five animals for a period of four weeks. Per kilogram body weight, 
four times the human dose of each drug was used as rats have a much 
greater ability to metabolise drugs. The control group received 
distilled water.
The results are shown in table 36. None of the drugs investigated 
affected the concentration of 20;5o)3 or 22:6io3 but both nitrazepam 
(p < 0.01) and diazepam (p < 0.02) reduced the concentration of 18:2w6.
All four drugs increased the concentration of 16:0 (nitrazepam, flurezepam
and diazepam; p * 0.02; chlormethiazole edisylate; p < 0,01).
(b) Effect of Diet
Dietary information was collected by 24-hour recall and dietary 
history (Mann et al,9 1962) from fifteen patients suffering from 
endogenous depression, fifteen patients suffering from reactive depression 
and fifteen controls. Weighed intakes were not feasible due to the 
commencement of treatment on the day after admission.
Dietary histories revealed that the frequency of eating foods which 
contain considerable amounts of 22;6w3 was similar in all three groups: 
liver, fish and chicken were eaten approximately once a week and egg two 
to three times per week. Total energy intakes (calculated from 24-hour 
recall) of patients with endogenous depression (p < 0.001) and of those 
with reactive depression (p < 0,00l)were significantly lower than those 
of controls (Table 37). However there were no differences in the 
proportions of energy derived from protein, fat or carbohydrate (Table 37)
Sanders (1977) showed that there was a correlation between protein 
intake and plasma viscosity. The plasma viscosities of patients suffering 
from endogenous or reactive depression were slightly lower than those of 
controls (Table 38) but the differences were not statistically significant
(c) Effect of Hormones
Fasting serum insulin, fasting blood glucose, serum thyroxine, plasma 
cyclic AMP and plasma 17-8-oestradiol concentrations were determined in 
psychiatric patients and controls. Plasma cyclic AMP and 17-B-oestradiol 
were only measured in men and postmenopausal women as they vary with the 
menstrual cycle (Holmes, 1975; Wright, 1971).
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TABLE 38
Plasma viscosity of patients suffering from depressive illness
Results expressed as mean ±S,E,
Endogenous depressives (22) 
Reactive depressives (20) 
Controls (22)
Plasma viscosity 
(cp)
1.62 ± 0.02 
1.64 ± 0.02 
1.67 ±0.02
Figures in parenthesis indicate the number of subjects studied. 
Differences between groups are not statistically significant. 
Statistical test employed; student t~test.
Fasting serum insulin (Table 39), fasting blood glucose (Table 39) 
and serum thyroxine concentrations (Figure 16) of patients suffering 
from endogenous depression were similar to those of patients suffering 
from reactive depression, patients with other psychiatric disorders 
and controls. Plasma cyclic AMP concentrations (Figure 17) were 
significantly lower (p < 0.05) in patients suffering from endogenous 
depression than in matched controls. Values for both patients and controls 
were similar to those reported by Lykouras et al. (1978), Plasma 
17-6-oestradiol concentrations of patients suffering from endogenous
i
depression did not differ significantly from those of matched controls 
(Figure 18).
Fasting serum insulin, the ratio of insulin to glucose, serum 
thyroxine and plasma 17-8-oestradiol did not correlate with the concentration 
of 22:6w3 in the plasma CPG, However a negative correlation was found 
between plasma cyclic AMP and the 22:6w3 concentration in the plasma CPG 
(r = -0.81, p < 0*01; Figure 19).
TABLE 39
Fasting serum insulin and fasting blood glucose 
Results expressed as mean ±S.E.
Insulin
(my/1)
Endogenous depressives (16) 7 ± 0.9
Reactive depressives (15) 8 ± 1.1
Other psychiatric patients (5) 8 ± 1.9
Controls (16) 7 ± 0.9
concentrations
Glucose 
(mmol/l)
4.4 ±0.08 
4.2 ± 0.10 
4.0 ± 0.12
4.4 ±0.13
Figures in parenthesis indicate the number of subjects studied. 
There are no significant differences between any of the groups. 
Statistical test employed: student t-test.
160
150
140
130
120
110
100
90
80
70
60
Figure 16
Serum thyroxine concentrations
_______t  I___________________I__________________ 1--- —
Endogenous Reactive Other Healthy
Depressives Depressives Psychiatric Controls
Patients
28
26
24
22
20
18
16
14
12
10
8
Figure 17
Plasma cyclic AMP concentrations
o o
— — = mean 
p « 0*05
JL
Endogenous Matched
Depressives Controls
54
50
46
42
38
34
30
26
22
18
14
10
Figure 18 - -
Plasma 17-B-oestradiol concentrations
o o
Endogenous Matched
Depressives Controls
= mean
75
70
65
60
55
50
45
40
35
30
25
20
phosphoglycerides against the plasma cyclic AMP concentrations
1.79x + 87.35
r = -0.81
p < 0.01
4
_J______ I______ L_
8 12 16 20 24 28
Cyclic AMP (pmol/ml)
Discussion
The effects of drugs, diet and hormones on phospholipid LCP 
composition have been examined in an attempt to discover the cause of 
the high LCP concentrations observed in patients suffering from 
endogenous depression.
Administration to adult female rats, of drugs taken by some of the 
patients in the study showed that they had no effect on the concentration 
of 20:5w3 or 22:6w3 in the plasma CPG. Although the results of animal 
experiments are not necessarily applicable to the human situation, they 
suggest that the high LCP concentrations in patients with endogenous 
depression are not an artifact of their chemotherapy. Both nitrazepam 
and diazepam reduced the concentration of 18:2w6 and therefore use of 
these drugs may be responsible, at least in part, for the low concentrations 
of this fatty acid in patients with endogenous depression. However, 
drug-free patients suffering from endogenous depression (for example 
those referred from general practitioners) also had lower 18:2w6 
concentrations than matched controls (chapter three), suggesting that 
other factors may also be involved.
Dietary histories revealed that patients suffering from endogenous 
depression did not consume greater quantities of foods containing 22:6w3 
than those suffering from reactive depression or controls and analysis of 
the 24-hour recalls showed that although the total energy intake of both 
groups of depressed patients was lower than that of controls, the 
proportions of energy derived from protein, carbohydrate and fat were 
similar in all three groups. This rules out the possibility of an 
increase in A6 desaturase activity produced by a-high protein or low 
carbohydrate diet. The other dietary factor which increases A6 desaturase 
activity is essential fatty acid deficiency. This would however result
in increased concentrations of 18:lw9 and 20;3oj9 and in reduced 
concentrations of 20:4w6 as well as 18:2w6. These differences were not 
observed in patients suffering from endogenous depression (see chapter 
three). Thus, although the dietary information is of limited value, 
it seems unlikely that the high concentrations of LCP observed in 
patients with endogenous depression are due to differences in diet.
Plasma cyclic AMP concentrations were significantly lower in patients 
suffering from endogenous depression than in controls (p < 0.05). This 
is in agreement with reports by other workers of low plasma (Holmes, 1975; 
Lykouras et al., 1978) and urinary (Abdullah and Hamadah, 1970; Paul 
et al,, 1970; Paul et al.9 1971; Naylor et ai,, 1974; Holmes, 1975;
Sinanan et al,\ 1975; Moyes and Moyes, 1976) cyclic AMP concentrations 
in patients with endogenous depression. Cyclic AMP depresses A6 
desaturase activity and therefore LCP synthesis will be ..increased when 
cyclic AMP is reduced. In the present study a negative correlation was 
found between plasma cyclic AMP and the concentration of 22:6w3 in the 
plasma CPG (r =.-0,81, p < 0.01), indicating that the high LCP concentrations 
in patients with endogenous depression may be a result of their low 
cyclic AMP concentrations. Plasma cyclic AMP has been shown to be increased 
by vigorous exercise (Holmes, 1975; Lin, 1978). However, the increase 
is transient (Holmes, 1975) and therefore differences in activity between 
patients and controls are unlikely to be responsible for the difference in 
plasma cyclic AMP concentrations.
ATP, from which cyclic AMP is formed, is a cofactor for A6 desaturase 
(Cook, 1978) and has been reported to induce the enzyme (Brenner, 1977). 
However a difference in ATP concentrations is unlikely to be responsible 
for the high LCP concentrations since blood levels of ATP have been 
found to be low (Hansen, 1972; Hansen and Dimitrakoudi, 1974) or normal 
(Naylor et a l , y 1976) in endogenous depression. Magnesium, another
cofactor of A6 desaturase (Cook, 1978) has been found to be low 
(Frizel et a l . ,  1969) and normal (Naylor et a l . ,  1972) in plasma and 
high (Bjorum, 1972; Hakim et a l . ,  1975a) in serum in endogenous depression. 
Hence, no conclusion can be reached as to whether the high LCP 
concentrations are related to an abnormality of magnesium metabolism.
Hormones which alter the acitivity of A6 desaturase exert their 
effect via cyclic AMP. The formation of cyclic AMP from ATP is catalysed 
by adenyl cyclase (Rail and Sutherland, 1962; Robison e t  a l . ,  1971). 
Thyroxine, glucagon and the catecholamines increase adenyl cyclase activity 
and thus increase cyclic AMP synthesis, whereas insulin has the opposite 
effect (Robison e t  a l . ,  1971; de Gomez Dumm e t  a l . ,  1977b). In the present 
study, no abnormality was found in fasting serum insulin, fasting blood 
glucose or serum thyroxine concentrations. Thus, in the light of the biogen 
amine hypothesis of affective disorders (Schildkraut, 1965; Bunney and 
Davis, 1965), it is possible that the low cyclic AMP concnetrations in 
patients with endogenous depression could be the result of a functional 
deficiency of catecholamines.
In conclusion, the high LCP concentrations in patients suffering 
from endogenous depression are thought to be due to an increase in A6 
desaturase activity produced by a decrease in cyclic AMP. However, there 
could also be an increase in the rate of incorporation of LCP into lipids 
and/or a decrease in phospholipase A^ in these patients.
CHAPTER SEVEN 
DISCUSSION
The preliminary observations of Ellis and Sanders (1977) of high 
LCP concentrations in the plasma CPG in endogenous depression have been 
confirmed in a larger series of patients. The present study showed 
that patients suffering from endogenous depression and those suffering 
from postpartum depression had higher concentrations of LCP and lower 
concentrations of 18:2w6 in their plasma CPG than matched controls, 
whereas women using oestrogen and progestogen combined oral contraceptive 
agents had lower LCP concentrations and higher concentrations of 18:2u)6 
than matched controls. Patients suffering from reactive depression, those 
suffering from other psychiatric disorders and women using progestogen- 
only oral contraceptive agents did not differ from matched controls in 
respect of any of the fatty acids. Differences in the fatty acid 
composition of the erythrocyte membrane phospholipids were in the same 
direction as those of the plasma CPG, but were less marked. It is likely 
that these differences are reflected in other tissues (Mohrhauer and 
Holman, 1963a,b,c), for example the liver and the brain.
Because of the difficulty of classifying some depressed patients as 
"endogenous” or "reactive" using existing clinical criteria, the possibility 
that measurement of the plasma CPG LCP concentrations might be of value 
as a diagnostic tool was investigated. Although the difference in LCP, 
in particular 22:6w3, between endogenous patients and matched controls 
was highly significant (p < 0.001), it was insufficient to be used as the 
sole diagnostic criterion (see chapter three). However, it may be of value 
in conjunction with other methods.
The differences in the fatty acid composition of the erythrocyte 
phospholipids may affect membrane function (van Deenan, 1971; McElhaney,
197*4; Lenaz, 1979) and this could possibly be of clinical importance.
An increase in the LCP content would tend to increase the fluidity of 
the membrane and hence increase its permeability and the activity of 
certain membrane-bound enzymes, for example Na K ATPase. A decrease in 
the LCP content would have the opposite effect. Mendels and Frazer 
(1973; 197*4; 1975) suggested that the high lithium ratios (RBC:plasma) 
in patients with manic-depressive illness, compared with those of controls, 
were due to a greater leak of lithium into the cell rather than to reduced 
active transport out of the cell, since lithium is not removed from 
the cell by Na+K+ATPase (Maizels, 1968; Duhm and Becker, 1977). However, 
studies of passive transport in patients suffering from manic-depressive 
illness have shown that this is normal (Frazer et a l . ,  1978) or low (Naylor 
et a l . ,  1970b), Studies of active transport have also been contradictory: 
both normal (Naylor et a l . ,  1973; Frazer et a l « ,  1978) and low (Naylor 
et a l . ,  1970b; Choi et a l . ,  1977; Hesketh et a l , ,  1977) values have been 
reported. Passive transport does not appear to have been studied in 
women using oestrogen and progestogen combined oral contraceptive agents. 
Active transport has been found to be normal (Kaplay and Ramanadham, 1978), 
If the results of Frazer et al. (1978) and Kaplay and Ramanadham (1978) 
are correct that is, there is no abnormality in either passive or active 
transport in patients with manic-depressive illness or in active transport 
in combined pill users, then it must be concluded that the observed 
differences in erythrocyte phospholipid fatty acid composition may be of 
insufficient magnitude to affect membrane function. However, if there is 
no abnormality in either passive or active transport in manic-depressive 
illness, how do the high lithium ratios occur in these patients?
Other factors which affect membrane function are. the relative 
proportions of phospholipids (Kimelberg and Papahadjopoulos, 1972; 
de Pont and Bonting, 1977; Cooper et al,% 1977; Borochov et al., 1977)
and the ratio of cholesterol:phospholipid CCooper, 1970; Cooper, 1978; Cooper 
et al., 1978; Le Grimellec and Leblanc, 1978; Owen and MacIntyre, 1978;
Chen et al., 1978) but these were normal in patients with endogenous 
depression. The protein content of the.:membrane may also affect its 
function (Lenaz, 1979) and this is a possibility for future study.
The fact that some LCP (20:3a)6, 20:*fw6 and 30;5w3) are precursors 
of prostaglandins and related compounds (Alfin-Slater and Aftergood, 1968; 
Galli et al., 1977) suggests that there may be abnormalities in the 
synthesis of these compounds in patients with endogenous depression, 
patients with postpartum depression and women using oestrogen and progestogen 
combined oral contraceptive agents. The rate of synthesis of prostaglandins 
is dependent upon the rate of release of the fatty acids from phospholipids, 
controlled by phospholipase A  ^(Horton, 1975; Schoene and Iacono, 1976;
Flower and Blackwell, 1976). It is not possible to.state with certainty 
the direction in which prostaglandin synthesis would be altered in each 
group because the activities of phospholipase A^ are unknown.
Phospholipids of women using oestrogen and progestogen combined oral 
contraceptive agents contained low concentrations of 20;Uw6 and 20:5w3.
High concentrations of 20:5w3 in lipids have been suggested to protect 
against thrombosis (Dyerberg et al., 1978) and therefore the low 
concentrations in combined pill users may be related to their risk of 
thrombosis. The phospholipids of patients with endogenous depression 
and of those with postpartum depression contained high concentrations of 
20:5w3. Treatment of endogenous depression by ECT or tricyclic
antidepressants was associated with a decrease in the concentration of this
fatty acid and in other LCP. Studies of the effect of electroconvulsive 
shock in rats (Bazan, 1970; Bazan and Rakowski, 1970; Bazan, 1971) showed
that the treatment produced an increase in brain free fatty acid
concentrations, in particular 20:4a)6. This was thought to be due to an
increased release of fatty acids from phospholipids. Hence it is 
possible that phospholipase activity may be low in endogenous 
depression with a resultant decrease in the synthesis of prostaglandins 
and related compounds. Brandrup and Randrup (1967) suggested that 
arteriosclerosis occurs more frequently in patients with manic-depressive 
illness than in controls. This does not seem to have been considered by 
more recent studies, but if correct may relate to the proposed low rate 
of release of 20:5w3 from phospholipids.
The importance of the high concentration of 22:6w3 in patients 
suffering from endogenous depression and in those suffering from postpartum 
depression remains to be discovered. This fatty acid occurs in high 
concentrations in membranes of the brain (Svennerholm, 1968; Crawford 
and Sinclair, 1972) and in the retina of the eye (Anderson and Maude,
1970; Borggreven et al., 1970; Nielsen et al., 1970) but its specific 
function is unknown.
The low total LCP concentration observed in women using oestrogen and 
progestogen combined oral contraceptive agents is of interest because 
this is the opposite of that observed in patients with endogenous depression 
and in those with postpartum depression. The low LCP was due to the 
oestrogen component of the pill since women using progestogen-only 
preparations had normal total LCP concentrations. Low concentrations of 
oestrogen and progesterone may play a role in the development of postpartum 
depression (Dalton, 1971) and therefore this suggests that a deficiency of 
oestrogen may be involved in the development of endogenous depression. 
However, the plasma 17-p-oestradiol concentrations of patients with endogenous 
depression were found to be similar to those of matched controls (see 
chapter six). Although the total LCP concentrations in patients with 
endogenous depression or postpartum depression were the opposite of those 
in combined pill users, there were differences in the individual fatty
acids which were affected. For example, the concentration of 22:6w3 
was high in patients with endogenous depression and in those with 
postpartum depression, but was normal in women using oestrogen and 
progestogen combined oral contraceptive agents; the concentration of 22:5ou3 
was low in the combined pill group, but was normal in patients with 
endogenous depression and in those with postpartum depression. Hence 
other factors must have been responsible for the high LCP in endogenous 
depression and postpartum depression.
The most likely reason for the high LCP concentrations in patients 
with endogenous depression or postpartum depression is a high A6 
desaturase activity. Factors affecting the activity of this enzyme were 
investigated in chapter six. Diet and drugs taken by some of the patients 
were unlikely to have produced the high LCP concentrations but hormonal 
factors may have been responsible. Plasma cyclic AMP concentrations 
were found to be significantly lower in patients with endogenous depression 
than in..matched controls, in agreement with other studies (Holmes, 1975; 
Lykouras et al,9 1978). A negative correlation was discovered between the 
plasma cyclic AMP concentrations and the concentrations of 22:6w3 in the 
plasma CPG. Thus, the high LCP concentrations were probably due to the 
lov; cyclic AMP concentrations, which in turn may have been the result of 
a functional deficiency of catecholamines (Schildkraut, 1965; Bunney 
and Davis, 1965; Kunitada et al,9 1978), It is interesting to note that 
A6 desaturase activity is lowest in summer (Peluffo and Brenner, 1974) 
when the incidence of depression is also low (Eastwood and Peacocke, 1976).
j
i
In addition to the proposed increase in A6 desaturase activity in 
endogenous and postpartum depression, there may be an increase in the 
rate of incorporation of LCP into lipids and/or a decrease in phospholipase 
A^ activity. The latter could be produced by a deficiency or noradrenalin
(Bazan et al,9 1971).
Further studies of passive transport are required in order to 
establish whether this is abnormal in patients suffering from endogenous 
depression, patients with postpartum depression and in women using 
oestrogen and progestogen combined oral contraceptive agents. Studies 
could also be undertaken to combine analyses of the lipid and protein 
components of the erythrocyte membrane with measurements of both passive 
and active transport in these three groups.
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APPENDIX
THE BECK INVENTORY
This is a questionnaire in which there are several groups 
of statements. We want you to circle the number of the one 
statement in each group which most accurately describes how 
you feel today - that is now.
If you feel that there are two or more statements in a group 
tha.t describe how you feel, then circle the statement with 
the higher number.
If there are two statements that you consider are equally ' 
applicable to you, then circle the one that best describes 
how you feel at present.
B e ‘sure to read all the statements in each group before making 
your choice.
NAME DATE
A. 0. I do not feel sad.
1. I feel sad.
2a I am sad all the time and I can't snap out of it
2b I am so sad or unhappy that it is quite painful.
3. I am so sad or unhappy that I.can’t stand it-
B. 0. I am not particularly pessimistic or discouraged about the future.
la I feel discouraged about the future.
2a I feel I have nothing to look for.vard to.
2b I feel that I won't ever get over my troubles.
3- I feel that the future is hopeless and that things cannot improve.
C. 0. I do not feel like a failure.
1. I feel I have failed more than the average person.
2a I feel I have accomplished very little that is worthwhile or that
means anything.
2b As I look back on my life all I can see is a lot of failures.
3- I feel I am a complete failure as a person (parent, husband, wife)
D. 0, I am not particularly dissatisfied. '
la I feel bored most of the time. s ■
lb I don't enjoy things the way I used to.
2. I don't get satisfaction out of anything any more.
3* I am dissatisfied with everything.
0. I don't feel particularly guilty.
1. I feel bad or-unworthy-a good part of the time.
2a I feel quite guilty.
2b I feel bad or unworthy practically all the time now.
3. I feel as though I am very bad or worthless.
E. 0. I don't feel I am being punished.
1. I have a feeling that something bad may happen to me.
2. I feel I am being punished or will be punished.
3a I feel I deserve to be punished.
3b I want to be punished. 1 • • .
G. 0. I don't feel disappointed in myself.
la I am disappointed in myself.
lb I don't like myself. • .
2. I am disgusted with myself.
3. I hate myself.
H. 0. I don't feel I am any worse than anybody else.
1. I am critical of myself for my weaknesses or mistakes.
2. I blame myself for my faults.
3. I blame myself for everything bad that happens.
I. 0. I don't have any thoughts of harming iiyself.
l. I have thoughts of harming myself but I would not carry them out.
2a I feel I would be better off dead.
2b I feel my family would be better off if X were dead.
3a I have definite plans about committing suicide.
3b I would kill myself if I could.
J. 0. I don't cry any more than usual.
1. I cry more no?/ than I used to. V
2. I cry all the time now, I can't.stop.
3. I used to be able to cry but now I can't cry at all even though
I want to.
K. 0. I am more irritated now than I ever was.
1. X get annoyed or irritated more easily than I used to.
2. I feel irritated all the time.
3. I don’t get irritated at all at the things that used to irritate me.
L. 0. I have not lost interest in other people.
1. I am less interested in other people now than I used to be.
2. I have lost most of my interest in other people and have little
feeling.for them.
3* I have lost all my interest in other people and don't care about 
them at all.
M, ' 0. I make decisions about as well as ever.
1. I try to put off making decisions.
2. I have great difficulty in making decisions.
3. I can't make any decisions at all any more.
N. 0. I don't feel I look any worse than I used to. •.
1. I am worried that I am looking old or unattractive.
2. I feel that there are permanent changes in my appearance and
they make me look unattractive.
0. 0. I can work about as well as before.
la It takes extra effort to get started at doing something, 
lb I don't work as well as I used to.
2. I have to push myself very hard to do anything.
3* I can't do any work at all,
P. 0. I can sleep as well as usual.
1. I wake up more tired in the morning than I used to.
2. I wake up 1-2 hours earlier than usual and find it hard.to get
back to sleep. *
3. I wake up early every day and can't get more than 5 hours sleep.
R. 0. My appetite is no worse than usual.
1. Mjy appetite is not as good as it used to be.
2. My appetite is much worse now.
3• I have no appetite at all any more.
S. 0. I have not lost much weight, if any, lately.
1. I have lost more than 5 pounds.
2. I have lost more than 10 pounds.
3* I have lost more than 15 pounds.
T. . 0. I am no more concerned about my health than usual.
1. I am concerned about aches and pains or upset stomach or constipation.
2. I am so concerned with how I feel or what I feel that it is hard to
think of much else.
3* I am completely absorbed in what I feel,
TT. 0. I have not noticed any recent change in my interest in sex.
1. I am less interested in sex than I used to be.
2. I am much less interested in sex now.
3. I have lost interest in sex completely.
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